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1. PUBLIC HEALTH STATEMENT 
This Statement was prepared to give you information about
acrylonitrile and to emphasize the human health effects that may result
from exposure to it. The Environmental Protection Agency (EPA) has
identified 1,177 sites on its National Priorities List (NPL).
Acrylonitrile has been found at 3 of these sites. However, we do not
know how many of the 1,177 NPL sites have been evaluated for
acrylonitrile. As EPA evaluates more sites, the number of sites at
which acrylonitrile is found may change. The information is important
for you to know because acrylonitrile may cause harmful health effects
and because these sites are potential or actual sources of human
exposure to acrylonitrile. 
When a chemical is released from a large area, such as an
industrial plant, or from a container, such as a drum or bottle, it
enters the environment as a chemical emission. This emission, which is
also called a release, does not always lead to exposure. You can be
exposed to a chemical only when you come into contact with the chemical.
You may be exposed to it in the environment by breathing, eating, or
drinking substances containing the chemical or from skin contact with
it. 
If you are exposed to a hazardous substance such as acrylonitrile,
several factors will determine whether harmful health effects will occur 
and what the type and severity of those health effects will be. These
factors include the dose (how much), the duration (how long), the route
or pathway by which you are exposed (breathing, eating, drinking, or
skin contact), the other chemicals to which you are exposed, and your
individual characteristics such as age, sex, nutritional status, family
traits, life style, and state of health. 
1.1 WHAT IS ACRYLONITRILE? 
Acrylonitrile is a colorless, liquid, man-made chemical with a
sharp, onion- or garlic-like odor. Acrylonitrile is used mostly to make
plastics, acrylic fibers, and synthetic rubber. Because acrylonitrile
evaporates quickly, it is most likely to be found in the air around
chemical plants where it is made. Acrylonitrile breaks down quickly in
the air. It has been found in small amounts in the water and soil near 
manufacturing plants and hazardous waste sites. In water, acrylonitrile
usually breaks down in about 1 to 2 weeks, although this can vary
depending on conditions. For example, high concentrations of
acrylonitrile (such as might occur after a spill) tend to be broken down
more slowly. In one case, measurable amounts of acrylonitrile were
found in nearby wells 1 year after a spill. Further information on the
properties and uses of acrylonitrile and how it behaves in the












1. PUBLIC HEALTH STATEMENT 
1.2 HOW MIGHT I BE EXPOSED TO ACRYLONITRILE? 
Unless you live near a factory where acrylonitrile is made or near
a hazardous waste site that contains acrylonitrile, you are unlikely to
be exposed to acrylonitrile in the air you breathe or the water you
drink. Concentrations of acrylonitrile in average air samples are too
low to be measured, and most water samples also have no measurable
acrylonitrile. Measurable amounts of acrylonitrile are found primarily
near factories and hazardous waste sites. Concentrations in the air 
near a factory producing or using acrylonitrile average less than 1 part
per billion (ppb). Extremely small amounts of acrylonitrile may be
found in water near some factories that make or use it, but
acrylonitrile rapidly breaks down and disappears from water. Plastic
food containers that are made from acrylonitrile are regulated by the
Food and Drug Administration such that only 0.17 ppb can enter food;
therefore, acrylonitrile intake from food packaging would be extremely
low. Because acrylonitrile has been found in water and soil in some
hazardous waste sites that contain this chemical, residents living very
close to waste sites might possibly be exposed to acrylonitrile by
breathing the air or drinking contaminated groundwater. 
Further information on how you might be exposed to acrylonitrile is
given in Chapter 5. 
1.3 HOW CAN ACRYLONITRILE ENTER AND LEAVE MY BODY? 
Acrylonitrile can enter your body if you breathe its vapors or eat
or drink acrylonitrile-contaminated food or water. Acrylonitrile can
pass through your skin, but how much gets through is not known. Inside
the body, acrylonitrile is broken down into other chemicals, including
cyanide. Most of these breakdown products are removed from the body in
the urine. Overall, most acrylonitrile is removed from the body within
24 hours, but approximately 25% of what is taken in becomes attached to
materials inside cells of the body. More information on how
acrylonitrile enters and leaves the body is given in CLaapter 2. 
1.4 HOW CAN ACRYLONITRILE AFFECT MY HEALTH? 
The effects of acrylonitrile on your health depend on how much you
take into your body and whether you are exposed for a short or long
period of time. If the levels of acrylonitrile are high enough, or if
the exposure is for a long enough period of time, acrylonitrile can
cause death. Small children are more likely to be affected than adults.
In several cases, children died following exposures that adults found
only mildly irritating. It should be noted that specific levels of
acrylonitrile causing death were not reported. Exposure to large
amounts of acrylonitrile for a short period of time, as might occur in












1. PUBLIC HEALTH STATEMENT 
nervous system. Symptoms can include headache and nausea. At higher
concentrations of acrylonitrile there may be temporary damage to red
blood cells and the liver. These symptoms disappear when the exposure
is stopped. 
Direct contact of your skin with acrylonitrile will damage the skin
so that it may blister and peel. Exposure of the skin to high
concentrations of acrylonitrile in the air may irritate the skin and
cause it to turn red. The redness may last for several days. 
Long-term exposure to acrylonitrile in air or water may increase
your chances of getting cancer. Humans who are repeatedly exposed to
acrylonitrile in the workplace for many years may have a higher-than-average
chance of developing lung cancer, although this is not clearly
established. In animals, exposure to acrylonitrile in the air or in
drinking water has been found to increase the number of tumors occurring
in the brain, salivary glands, and intestines. 
Birth defects have been seen in animals exposed to high
concentrations of acrylonitrile in the air or drinking water.
Reproductive effects have been seen in animals given acrylonitrile in
drinking water for three generations. However, no birth defects or
effects on reproduction have been reported in humans. 
Further information on the health effects of acrylonitrile in
humans and animals can be found in Chapter 2. 
1.5 WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS? 
In humans, breathing acrylonitrile at a concentration of 16 parts
of acrylonitrile per million parts of air (ppm) causes headaches,
nausea, and disorientation (Table l-l). This concentration is close to
that at which acrylonitrile can be smelled in air (about 21 ppm).
Breathing acrylonitrile in air for long periods of time and at high
concentrations can cause death. The actual concentrations of 
acrylonitrile and breathing times which cause death have not been
measured. There is no information on human health effects from eating
or drinking acrylonitrile. Acrylonitrile can be smelled at a
concentration of 19 ppm when dissolved in water. 
In animals, drinking water that contains 142 ppm of acrylonitrile
has caused nervous system disorders leading to death (Table l-4). Birth
defects and effects on reproduction have occurred in animals that
breathed acrylonitrile in air at levels of 80 ppm or drank it in water













1. PUBLIC HEALTH STATEMENT 
Tables l-1 through 1-4 show the relationship between exposure to
acrylonitrile and known health effects. Short-term and longer-term
Minimal Risk Levels (MRLs) are also included in Tables l-l and l-3.
These MRLs were derived from animal and human data for both short-term 
and long-term exposure, as described in Chapter 2 and in Tables 2-l and
2-2. The MRLs provide a basis for comparison with levels that people
might encounter either in the air or in food or drinking water. If a
person is exposed to acrylonitrile at an amount below the MRL, it is not
expected that harmful (noncancer) health effects will occur. Because
these levels are based only on information currently available, some
uncertainty is always associated with them. Also, because the method
for deriving MRLs does not use any information about cancer, an MRL does
not imply anything about the presence, absence, or level of risk for
cancer. 
Additional information on the levels of exposure associated with
harmful effects can be found in Chapter 2. 
1.6 	 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO 
ACRYLONITRILE? 
There is a test that can detect acrylonitrile in blood. In
addition, the major breakdown products of acrylonitrile by the body
(termed metabolites) can be measured in urine. Some breakdown products
that can be measured are specific to acrylonitrile. However, one
breakdown product of the body (cyanide) that is commonly measured is not
specific to acrylonitrile exposure, and the results can be affected by
cigarette smoking. Because special equipment is needed, these tests
cannot be performed routinely in your doctor's office. There is not
enough information at present to use the results of such tests to
predict the nature or severity of any health effects that may result
from exposure to acrylonitrile. Further information on how
acrylonitrile can be measured in exposed humans is presented in
Chapters 2 and 6. 
1.7 	 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT 
HUMAN HEALTH? 
The federal government has developed regulations and advisories to
protect individuals from the potential health effects of acrylonitrile
in the environment. The U.S. Environmental Protection Agency (EPA)
recommends that acrylonitrile levels in water not exceed 0.058 ppb. Any
release to the environment of more than 100 lb must be reported to the
federal government. The Occupational Safety and Health Administration
(OSHA) has established a legally enforceable maximum limit of 2 ppm in






1. PUBLIC HEALTH STATEMENT 
Additional information on governmental regulations can be found Chapter
7. 
1.8 WHERE CAN I GET MORE INFORMATION? 
If you have any more questions or concerns not covered here, please
contact your State Health or Environmental Depart or: 
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333 
This agency can also give you information on the location of the nearest
occupational and environmental health clinics. Such clinics specialize in
recognizing, evaluating, and treating illnesses that



































































2. HEALTH EFFECTS 
2.1 INTRODUCTION 

This chapter contains descriptions and evaluations of studies and
interpretation of data on the health effects associated with exposure to
acrylonitrile. Its purpose is to present levels of significant exposure
for acrylonitrile based on toxicological studies, epidemiological
investigations, and environmental exposure data. This information is
presented to provide public health officials, physicians, toxicologists,
and other interested individuals and groups with (1) an overall
perspective of the toxicology of acrylonitrile and (2) a depiction of
significant exposure levels associated with various adverse health
effects. 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals address the needs of persons
living or working near hazardous waste sites, the data in this section
are organized first by route of exposure -- inhalation, oral, and dermal
-- and then by health effect -- death, systemic, immunological,
neurological, developmental, reproductive, genotoxic, and carcinogenic
effects. These data are discussed in terms of three exposure periods --
acute, intermediate, and chronic. 
Levels of significant exposure for each exposure route and duration
(for which data exist) are presented in tables and illustrated in
figures. The points in the figures showing no-observed-adverse-effect
levels (NOAELs) or lowest-observed-adverse-effect levels (LOAELs)
reflect the actual doses (levels of exposure) used in the studies.
LOAELs have been classified into "less serious" or "serious" effects. These 
distinctions are intended to help the users of the document
identify the levels of exposure at which adverse health effects start to
appear, determine whether or not the intensity of the effects varies
with dose and/or duration, and place into perspective the possible
significance of these effects to human health. 
The significance of the exposure levels shown on the tables and
figures may differ depending on the user's perspective. For example,
physicians concerned with the interpretation of clinical findings in
exposed persons or with the identification of persons with the potential
to develop such disease may be interested in levels of exposure
associated with "serious" effects. Public health officials and project
managers concerned with response actions at Superfund sites may want
information on levels of exposure associated with more subtle effects in
humans or animals (LOAELS) or exposure levels below which no adverse
effects (NOAELs) have been observed. Estimates of levels posing minimal
risk to humans (Minimal Risk Levels, MRLs) are of interest to health












2. HEALTH EFFECTS 
For certain chemicals, levels of exposure associated with
carcinogenic effects may be indicated in the figures. These levels
reflect the actual doses associated with the tumor incidences reported
in the studies cited. Because cancer effects could occur at lower 
exposure levels, the figures also show estimated excess risks, ranging
from a risk of one in 10,000 to one in 10,000,000 (10-4 to 10-7), as
developed by EPA. 
Estimates of exposure levels posing minimal risk to humans (MRLs)
have been made, where data were believed reliable, for the most
sensitive noncancer end point for each exposure duration. MRLs include
adjustments to reflect human variability and, where appropriate, the
uncertainty of extrapolating from laboratory animal data to humans.
Although methods have been established to derive these levels (Barnes
et al. 1987; EPA 1989a), uncertainties are associated with the
techniques. Furthermore, ATSDR acknowledges additional uncertainties
inherent in the application of these procedures to derive less than
lifetime MRLs. As an example, acute inhalation MRLs may not be
protective for health effects that are delayed in development or are
acquired following repeated acute insults, such as hypersensitivity
reactions, asthma, or chronic bronchitis. As these kinds of health
effects data become available and methods to assess levels of 
significant human exposure improve, these MRLs will be revised. 
2.2.1 Inhalation Exposure 
Table 2-l and Figure 2-l summarize quantitative data on the health
effects observed in humans and laboratory animals exposed to
acrylonitrile by inhalation. 
2.2.1.1 Death 
In humans, the death of a child (age 3) who was exposed by sleeping
in a room that had been fumigated with acrylonitrile has been described
by Grunske (1949). Respiratory malfunction, lip cyanosis and
tachycardia were among the symptoms described prior to death. Five
adults who spent the night in the same room complained only of eye
irritation or showed no signs of acrylonitrile poisoning. The
concentrations of acrylonitrile in the air were not reported. Several
other instances of death in children with only mild irritation in adults
were reported by Grunske (1949), but not described in detail. 
Data on the NOAELS and LOAELS for death are presented in Table 2-l
for several animal species. The data presented indicate that species
differences exist with respect to acute lethal effects. Dogs appear to
be the most susceptible species, but this is based on studies involving
only a few animals. The cause of death varied among test species. In





















2. HEALTH EFFECTS 
Section 2.2.1.2) while in the other species convulsions and coma
occurred (see Section 2.2.1.4) (Dudley and Neal 1942). It should be
noted that this study is based on nominal concentrations without
analytical verification. 
Chronic exposure to acrylonitrile has been reported to result in
early deaths in male and female rats (Quast et al. 1980a). A
statistically significant increase in mortality was observed within the
first year of a study in which animals were exposed to 80 ppm of
acrylonitrile. At 20 ppm, increased deaths were noted in females during
the last 10 weeks of the study. The cause of death was not specifically
identified. 
The highest NOAEL values and all reliable LOAEL values for death in
each species and duration category are recorded in Table 2-l and plotted
in Figure 2-l. 
2.2.1.2 Systemic Effects 
Respiratory Effects. In workers exposed to acrylonitrile at
concentrations of 16 to 100 ppm for periods of 20 to 45 minutes,
irritation of the nose and throat and a feeling of fullness in the chest
was reported by Wilson et al. (1948). 
Acute effects on the respiratory tract of animals demonstrate
species differences. In guinea pigs exposed to 575 ppm for 4 hours,
marked irritation of the respiratory tract was evidenced by coughing and
nasal exudate, with delayed death from lung edema (Dudley and Neal
1942). In other species (rats, rabbits, dogs and monkeys), death
occurred at lower doses than in guinea pigs, but was not related to
respiratory effects. In these animals, mild irritation of the
respiratory tract and effects resembling cyanide poisoning were noted.
Respiration was initially stimulated, but then followed by rapid shallow
breathing (Dudley and Neal 1942). 
Reported exposure at lower doses shows no acrylonitrile-related
effects on the respiratory system. For example, rats repeatedly exposed
for 5 days to 129 ppm of acrylonitrile showed no gross or histological
changes in lung tissue (Gut et al. 1984). However, chronic exposure of
rats to acrylonitrile appears to cause irritation of the nasal passages.
In a 2-year study, histopathological evaluation of tissues of the
respiratory system revealed degenerative and inflammatory changes of the
nasal turbinates at 80 ppm (Quast et al. 1980a). These effects were not
















2. HEALTH EFFECTS 
The highest NOAEL values and all reliable LOAEL values for
respiratory effects in each species and duration category are recorded
in Table 2-l and plotted in Figure 2-l. 
Cardiovascular Effects. In humans, tachycardia was among the
symptoms described in a child (age 3) who was exposed by sleeping in a
room that had been fumigated with acrylonitrile. The child died as a
result of the exposure (see Section 2.2.1.1) (Grunske 1949).
No studies were located regarding cardiovascular effects in animals
following inhalation exposure to acrylonitrile. 
Gastrointestinal Effects. Though tumors of the small intestine
were noted in a comprehensive and well-conducted study by Quast et al.
(1980a) (see Section 2.2.1.8), there were no nonneoplastic
histopathologic changes observed in any portion of the gastrointestinal
tract of rats at doses up to 80 ppm for 2 years. 
Hematological Effects. Humans exposed to acrylonitrile at
concentrations where nausea, vomiting and weakness occurred (16 to
100 ppm for 20 to 45 minutes), were also reported to have low grade
anemia. However, complete recovery after cessation of exposure was
reported (Wilson 1944; Wilson et al. 1948). No adverse hematological
effects were detected in Japanese workers exposed to acrylonitrile for
10 to 13 years at exposure levels averaging 2.1 to 14.1 ppm (Sakurai
et al. 1978). 
In a chronic study in rats (Quast et al. 1980a), some changes in
the blood parameters measured were observed at various intervals during
the study, but the findings did not occur consistently and were not
dose-related. Therefore, the authors concluded that these findings were
not direct effects of exposure to acrylonitrile, but rather were a
secondary response to other effects such as weight loss, tumor
formation, or inflammatory reactions. 
The highest NOAEL values and all reliable LOAEL values for
hematological effects in each species and duration category are recorded
in Table 2-l and plotted in Figure 2-l. 
Musculoskeletal Effects. No studies were located regarding
musculoskeletal effects in humans or animals following inhalation
exposure to acrylonitrile. 
Hepatic Effects. Acrylonitrile is metabolized in the liver to
potentially toxic metabolites (see Section 2.3). There are limited














2. HEALTH EFFECTS 
In humans, mild jaundice lasting several days to 4 weeks has been
observed after acute occupational exposure to acrylonitrile vapors at
high concentrations (Wilson 1944); however, the concentrations of
acrylonitrile to which workers were exposed were not reported. The
effects were fully reversible. In factory workers exposed to
acrylonitrile for 10 years or more, Sakurai et al. (1978) reported an
increase in palpable livers of workers. However, the authors considered
these results to be inconclusive because the increase was not 
statistically significant and subjective judgments were involved. Also,
blood chemistry evaluations did not indicate liver damage. 
In animals, acrylonitrile does not appear to cause damage to the
liver following acute or chronic inhalation exposure, though some
biochemical changes are noted. Exposure of rats for 5 days to 129 ppm
of acrylonitrile resulted in slightly lower liver weight, but no
histopathological changes were found (Gut et al. 1984). Depletion of
glutathione and effects on carbohydrate and lipid metabolism were
observed (Gut et al. 1984, 1985). These effects would be expected
considering the affinity of acrylonitrile for sulfhydryl groups on
proteins and the involvement of glutathione in the metabolism of
acrylonitrile (see Section 2.6). A 2-year chronic study in rats showed
no liver injury as evaluated by serum enzyme activity and
histopathological evaluation of the tissue (Quast et al. 1980a). 
The highest NOAEL values and all reliable LOAEL values for hepatic
effects in each species and duration category are recorded in Table 2-l
and plotted in Figure 2-l. 
Renal Effects. Most studies indicate that inhalation exposure to
acrylonitrile does not result in significant kidney injury. For
example, physical examination of workers exposed to acrylonitrile vapors
in the workplace for 10 or more years provided no indication of renal
effects (Sakurai et al. 1978). In animals, no histological or
biochemical signs of renal injury were seen following exposure of rats
to 129 ppm of acrylonitrile for 5 days (Gut et al. 1984), or to 80 ppm 
for 2 years (Quast et al. 1980a). Small increases in urinary levels of
glucose, gamma-glutamyl transpeptidase, and N-acetyl-glucosaminidase
were observed in rats exposed to 200 ppm of acrylonitrile for 4 hours
(Rouisse et al. 1986), but this was not accompanied by any significant
effect on urinary creatinine or blood urea nitrogen. No significant
effects were noted at 100 ppm for this duration of exposure. 
The highest NOAEL values and all reliable LOAEL values for renal
effects in each species and duration category are recorded in Table 2-1














2. HEALTH EFFECTS 
Dermal/Ocular Effects. In humans, direct skin irritation resulting
from exposure to acrylonitrile vapors has been observed (see Section
2.2.3). 
A skin redness reported in experimental animals (rats, rabbits,
cats and monkeys) after inhalation exposure to acrylonitrile may be due
to a vasodilatory effect, rather than a direct irritant action (Ahmed
and Pate1 1981). Guinea pigs, which do not exhibit the cyanide-type
effects of acrylonitrile poisoning (see Section 2.2.1.4), were observed
to have nose and eye irritation from the acrylonitrile vapors (Dudley
and Neal 1942). 
The highest NOAEL values and all reliable LOAEL values for
dermal/ocular effects in each species and duration category are recorded
in Table 2-l and plotted in Figure 2-l. 
2.2.1.3 Immunological Effects 
No studies were located regarding immunologic effects in humans or
animals following inhalation exposure to acrylonitrile. 
2.2.1.4 Neurological Effects 
In humans, acute exposure to acrylonitrile results in
characteristics of cyanide-type toxicity. Symptoms in humans associated
with acrylonitrile poisoning include limb weakness, labored and
irregular breathing, dizziness and impaired judgment, cyanosis, nausea,
collapse, and convulsions (Baxter 1979). However, the doses that
produce these effects were not clearly defined. Workers exposed to 16
to 100 ppm for 20 to 45 minutes complained of headaches and nausea,
apprehension and nervous irritation (Wilson et al. 1948). The workers
exposed to acrylonitrile vapors fully recovered. In a study with human
volunteers exposed to acrylonitrile at doses of 2.3 and 4.6 ppm, no
symptoms attributable to effects on the nervous system were observed
(Jakubowski et al. 1987). The dose of 4.6 ppm was used to calculate the
acute inhalation MRL of 0.1 ppm, as described in the footnote in
Table 2-l. 
Animals exposed to acrylonitrile usually display acute neurological
symptoms. Dogs appear to be particularly sensitive. Excessive
salivation in dogs occurred at concentrations of 30 ppm of
acrylonitrile, and paralysis of the hind limbs occurred at 100 ppm. In
cats, excessive salivation occurred at 100 ppm; at 275 ppm animals were
observed to paw their heads and stomachs and howl as if in pain. In
monkeys, "weakness" was reported at 90 ppm, but higher doses were not
tested. Guinea pigs showed no measurable signs of neurological effects

















2. HEALTH EFFECTS 
(575 ppm) (Dudley and Neal 1942). It should be noted that this study is
based on nominal concentrations with no analytical verification.
Therefore, the overall usefulness of the study is limited. 
Chronic exposure of rats to 80 ppm acrylonitrile resulted in focal
gliosis and perivascular cuffing in the brain (Quast et al. 1980a). The
gliosis appeared to be a pre-malignant lesion related to the formation 
of brain tumors, and is discussed in more detail in Section 2.2.1.8
(below). 
The highest NOAEL values and all reliable LOAEL values for
neurological effects are recorded in Table 2-l and plotted Figure 2-l. 
2.2.1.5 Developmental Effects 
Inhalation exposure to acrylonitrile results in teratogenic effects
in rats. Inhalation of 80 ppm acrylonitrile during days 6 to 15 of
gestation (the critical period of organogenesis) resulted in a
significant increase in fetal malformations. These malformations
included short tail, missing vertebrae, short trunk, omphalocele and
hemivertebra. In this well-conducted study, mean number of
implantations, live fetus and resorptions were not significantly altered
by exposure to 40 or 80 ppm of acrylonitrile. No effects on fetal body
size were evident. Maternal toxicity was observed at both dose levels
tested (40 and 80 ppm), as evidenced by decreased weight gain (Murray
et al. 1978). 
2.2.1.6 Reproductive Effects 
No studies were located regarding reproductive effects in humans or
animals following inhalation exposure to acrylonitrile. 
2.2.1.7 Genotoxic Effects 
Factory workers exposed for an average of 15 years to acrylonitrile
vapors showed no increase in chromosomal aberrations in the peripheral
lymphocytes (Thiess and Fleig 1978). As in most human studies, the
actual concentration of acrylonitrile to which these workers were
exposed was not reported. However, monitoring data indicated that the
average exposure concentration for the workers was 5 ppm for the
majority of the exposure period (approximately 10 years); at the time
the study was conducted, acrylonitrile levels in the workplace had been
reduced to 1.5 ppm. 
No studies were located regarding genotoxic effects in animals













2. HEALTH EFFECTS 
2.2.1.8 Cancer 
A number of epidemiological studies have been conducted to evaluate
the association between lung cancer and occupational exposure to
acrylonitrile (Collins et al. 1989; Delzell and Monson 1982; Kiesselbach
et al. 1979; O'Berg 1980; O'Berg et al. 1985). However, many of the
studies suffer from deficiencies such as an insufficient quantification
of exposure, short follow-up, small and relatively youthful cohorts or
lack of consideration of the effects of smoking, and the results of the
studies are often inconsistent. 
The most reliable of the epidemiology studies on acrylonitrile is
that conducted by O'Berg (1980) in which 1,345 male workers in a textile
factory were followed over a period of 25 years. Exposures to
acrylonitrile were divided into three groups (low, medium and high),
although quantitative estimates of exposure levels were not assigned.
O'Berg (1980) concluded that there may be an association between human
lung cancer and acrylonitrile inhalation exposure. The incidence of
cancer did not increase significantly in exposed workers over the
unexposed population. The data from this on-going study were updated by
O'Berg et al. (1985) to include an additional 7 years of follow-up.
Though an increased incidence of lung cancer in workers exposed to
acrylonitrile was observed, the effect was not as pronounced as it had
been in the previous report. The authors concluded that continued
follow-up was needed. 
Statistically significant cancer excesses have been observed in
other studies; however, due to limitations in the studies firm
conclusions cannot be made. In an analysis of mortality among 327
rubber workers, nine deaths from lung cancer were observed compared to
4.7 to 5.9 expected deaths among the general population and other rubber
workers (Delzell and Monson 1982). The observed and expected numbers of
death were small and the study did not evaluate cigarette smoking as a
confounding factor contributing to excess death. 
Another well-designed epidemiology study (Collins et al. 1989) did
not find an increased risk of lung cancer from acrylonitrile exposure.
In this study, 2,671 males (1,774 with known acrylonitrile exposure)
were followed for 32 years. Workers in acrylic fiber manufacturing
plants were categorized into four dose ranges (expressed in ppm/year).
Smoking histories were taken into consideration. No significant
relationship between lung cancer and acrylonitrile exposure was
established, although the authors found some evidence in this study of
confounding association between smoking status and cumulative exposure
to acrylonitrile. In this study, as in the previously discussed studies














2. HEALTH EFFECTS 
and only 9% of the cohort had died. Additional follow-up will be
necessary to determine whether death can be associated with cancers
resulting from acrylonitrile exposure. 
Epidemiology studies have also suggested a possible association
between acrylonitrile exposure and prostate cancer (Chen et al. 1987;
O'Berg et al. 1985), but the data are too limited to warrant any firm
conclusion. Collins et al. (1989) found no increase in prostate cancer
in acrylonitrile-exposed workers, but again the data are too limited to
be meaningful. 
Deaths from cancer of the stomach were statistically elevated in
one study of six manufacturing plants in the United Kingdom involved in
the polymerization of acrylonitrile and the spinning of acrylic fibers
(Werner and Carter 1981). No quantitative data on the exposure levels
to acrylonitrile were given and the numbers of expected deaths was too
small to provide confidence in the results. 
In animals, chronic studies provide convincing evidence that
acrylonitrile is carcinogenic when administered by the inhalation route
of exposure. Tumors in the brain, Zymbal gland and mammary glands in
rats exposed to acrylonitrile for 2 years were reported by both Quast
et al. (1980a) and Maltoni et al. (1988). Quast et al. (1980a) reported
two types of lesions in the central nervous system: astrocytomas and
focal or multifocal glial cell proliferation. The glial cell
proliferation was considered to be a microscopic change suggestive of
early tumorigenesis. Brain tumors were observed in males exposed to
80 ppm of acrylonitrile, and in females at 20 and 80 ppm. In addition,
Quast et al. (1980a) reported tumors of the tongue and small intestine
in males (80 ppm). Maltoni et al. (1988) noted tumors in the liver
(60 ppm). 
2.2.2 Oral Exposure 
No studies were located regarding health effects in humans
associated with the oral ingestion of acrylonitrile. Table 2-2 and
Figure 2-2 summarize the health effects observed in experimental animals
following oral exposure to acrylonitrile. These effects are discussed
below. 
2.2.2.1 Death 
The acute oral LD50 has been estimated to be 93 mg acrylonitrile/kg
body weight (mg/kg) in rats (Back et al. 1972) and 27 mg/kg for mice
(Ahmed and Pate1 1981). Longer term intake (6 months) in dogs at
16 mg/kg/day resulted in early deaths. Animals lost weight and were






















2. HEALTH EFFECTS 

Chronic studies in rats indicate that lifetime exposure to doses of
4.4 mg acrylonitrile/kg body weight/day (mg/kg/day) or higher may result
in premature death (Bio/dynamics 1980a, 1980b, 1980c; Gallagher et al.
1988; Quast et al. 1980b). The cause of death was not specifically
identified. 
The highest NOAEL values and all reliable LOAEL values for death in
each species and duration category are recorded in Table 2-2 and plotted
in Figure 2-2. 
2.2.2.2 Systemic Effects 
Respiratory Effects. Chronic oral exposure of animals to low
levels of acrylonitrile has not been found to result in damage to the
lungs. Histopathological evaluation of lung tissues from rats showed no
lung injury at doses up to 25 mg/kg/day for 2 years (Bio/dynamics 1980a,
1980b, 1980c; Quast et al. 1980b). 
Cardiovascular Effects. No injury to the cardiovascular system has
been detected in studies in animals. No effects were seen in dogs
exposed to 18 mg/kg/day in drinking water for 6 months (Quast et al.
1975). In chronic studies in rats exposed to 14 mg/kg/day in drinking
water (Bio/dynamics 1980b) or by gavage (Bio/dynamics 198Oc), an
increased heart-to-body-weight ratio was observed. However, the effects
were not seen in other studies where acrylonitrile was given to rats in
drinking water (Bio/dynamics 1980a; Quast et al. 1980b). No
histopathological changes were reported in heart tissues in any of the
chronic studies (Bio/dynamics 1980a, 1980b, 1980c; Quast et al. 1980b). 
The highest NOAEL values and all reliable LOAEL values for
cardiovascular effects in each species and duration category are
recorded in Table 2-2 and plotted in Figure 2-2. 
Gastrointestinal Effects. Studies in animals suggest that oral
exposure to acrylonitrile is irritating to the esophagus and stomach.
An acute oral dose of acrylonitrile resulted in hemorrhagic necrosis of
the forestomach of rats (Szabo et al. 1984). In dogs given
acrylonitrile in drinking water for 6 months at 16 mg/kg/day, gross and
microscopic evaluation showed focal erosions and ulcerations in the
esophagus (Quast et al. 1975). The authors considered these lesions to
be due to irritation to the mucous membranes, No esophageal lesions
were present at 10 mg/kg/day. Rats given acrylonitrile in drinking
water for 50 weeks at doses up to 70 mg/kg/day showed no effects on the
gastrointestinal tract (Beliles et al. 1980), indicating that rats are
less sensitive to this effect than dogs. Rats exposed to acrylonitrile
in drinking water for 2 years developed papillomatous proliferations of





7.1 mg/kg/day (Gallagher et al. 1988). This effect is discussed under
Section 2.2.2.8 below. Nonproliferative effects on the stomach were not
reported. 
The method by which an oral dose is administered may also determine
whether gastrointestinal effects occur. While no effects were observed
in rats given acrylonitrile in drinking water at doses up to
70 mg/kg/day for 50 weeks (Beliles et al. 1980), administration by
gavage of 25 mg/kg/day acrylonitrile to rats for 10 days resulted in
thickening of the nonglandular portion of the stomach (Murray et al.
1978). A single gavage dose of 50 mg/kg to rats was reported to cause
gastrointestinal bleeding, as measured by increased heme content in the
gastrointestinal tract (Ghanayem and Ahmed 1983). 
The highest NOAEL values and all reliable LOAEL values for gastro-
ntestinal effects in each species and duration category are recorded in Table
2-2 and plotted in Figure 2-2. 
Hematological Effects. Decreased red blood cell counts, hematocrit,
and hemoglobin content have been reported following acute, intermediate
and chronic oral studies in animals (Bio/dynamics 1980a, 1980b,
198Oc; Farooqui and Ahmed 1983a; Quast et al. 1975). Although the
mechanism of these hemotoxic effects is not clear, Farooqui and Ahmed
(1983) found that acrylonitrile bound covalently both to red blood cell
membranes and to hemoglobin. In dogs administered acrylonitrile at
doses up to 18 mg/kg/day for 6 months, decreased red cell counts,
hematocrit, and hemoglobin content were seen only in animals that died
(Quast et al. 1975). In chronic studies in rats, lower red cell
parameters were seen at 14 mg/kg/day, but these effects were not
specifically identified with animals that died during the study
(Bio/dynamics 1980a, 1980b, 1980c). In another chronic study in rats at
doses up to 25 mg/kg/day for 2 years, no effects on red cell parameters
were observed, though early deaths were observed in the study (Quast
et al. 1980b). Based on lower red cell parameters (Bio/dynamics 1982a),
a chronic oral MRL of 0.04 mg/kg/day was calculated as described in the
footnote in Table 2-2. 
The highest NOAEL values and all reliable LOAEL values for
hematological effects in each species and duration category are recorded
in Table 2-2 and plotted in Figure 2-2. 
Musculoskeletal Effects. No studies were located regarding
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Hepatic Effects. Although acrylonitrile is metabolized by the
liver to potentially toxic metabolites (see Section 2.3.3), the liver
does not appear to be an important target organ for acrylonitrile
toxicity (Silver et al. 1982). In chronic studies in rats, microscopic
examination of liver tissue showed no damage after 2 years of exposure
to acrylonitrile at doses up to 25 mg/kg/day (Bio/dynamics 1980a, 1980b,
198Oc; Quast et al. 1980b). 
Some effects in the liver have been reported, but they may be
adaptive changes related to increased metabolic activity. Increased
glutathione levels were reported at doses of 70 mg/kg/day for 21 days
(Szabo et al. 1977). Because the metabolism of acrylonitrile includes
pathways that utilize glutathione (see Section 2.3.3), the higher
glutathione levels in the liver may be due to increased demand for
glutathione for the metabolism of acrylonitrile. 
A consistent observation in rats exposed to acrylonitrile was
increased liver weight, both in acute studies at 65 mg/kg/day (Murray
et al. 1978) and chronic studies at 10 mg/kg/day (Bio/dynamics 1980a,
1980b, 1980c). Again, this may be an adaptive change related to
increased metabolic activity by the liver due to the presence of
acrylonitrile in the body. 
The highest NOAEL values and all reliable LOAEL values for hepatic
effects in each species and duration category are recorded in Table 2-2
and plotted in Figure 2-2. 
Renal Effects. No adverse effects on the renal system have been
reported in animals administered acrylonitrile via the oral route. In
chronic studies in rats, increased kidney weights relative to body
weight were observed (Bio/dynamics 1980a, 1980b, 1980c). However, the
significance of this observation, if any, is not known, because no
histopathological, blood chemistry, or urinalysis findings suggestive of
kidney injury were observed in intermediate and chronic studies in rats
or dogs (Bio/dynamics 1980a, 1980b, 1980c; Quast et al. 1975, 1980b). 
The highest NOAEL values and all reliable LOAEL values for renal
effects in each species and duration category are recorded in Table 2-2
and plotted in Figure 2-2. 
Dermal/Ocular Effects. No studies were located regarding dermal or
ocular effects in humans or animals following oral exposure to
acrylonitrile. 
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Other Systemic Effects. Decreased adrenal weight, adrenal atrophy,
and decreased aldosterone and corticosterone levels in plasma were
observed in rats administered acrylonitrile in drinking water for
3 weeks at 70 mg/kg/day (Szabo et al. 1984). Similar effects were
observed when the dosing period was extended to 60 days (Szabo et al.
1984). However, no effects on adrenal weight or histopathology of the
adrenals were observed in several chronic studies in which doses were 
similar to the 21- and 60-day studies by Szabo et al. (1984)
(Bio/dynamics 1980a, 1980b, 198Oc; Quast et al. 1980b). 
The highest NOAEL values and all reliable LOAEL values for other
systemic effects in each species and duration category are recorded in
Table 2-2 and plotted in Figure 2-2. 
2.2.2.3 Immunological Effects 
No studies were located regarding immunologic effects in humans or
animals following oral exposure to acrylonitrile. 
2.2.2.4 Neurological Effects 
Exposure to acrylonitrile caused effects similar to those of
cyanide poisoning. Intermediate and chronic exposure of animals to
acrylonitrile resulted in decreased activity and depression (Beliles et
al. 1980; Bigner et al. 1986; Quast et al. 1975). Species differences
are apparent, dogs being more susceptible than rats. In dogs
administered acrylonitrile for 6 months at 16 mg/kg/day, depression and
lethargy were reported, with the majority of the experimental groups
animals dying before the end of the study period (Quast et al. 1975).
In rats, acute exposure results in a transient cholinomimetic
stimulatory phase (salivation, diarrhea, lachrymation, vasodilation),
followed by a central nervous system depression (Ahmed and Farooqui
1982; Ahmed and Pate1 1981). In rats exposed for 1 to 2 years at
70 mg/kg/day, decreased activity, abnormal gait, and prostration were
noted but no deaths were reported (Beliles et al. 1980; Bigner et al.
1986). No histopathological changes in the nervous system were reported
except those related to tumor formation (see Section 2.2.2.8) (Beliles
et al. 1980). 
The highest NOAEL values and all reliable LOAEL values for
neurological effects in each species and duration category are recorded
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2.2.2.5 Developmental Effects 
Oral exposure to acrylonitrile has been shown to result in
teratogenic effects in rats (Murray et al. 1978). Oral administration
of 25 mg/kg/day of acrylonitrile during days 6 to 15 of gestation
resulted in an increased incidence of malformations. Although the
incidence of malformations at 25 mg/kg/day was not statistically
significant, the authors considered them related to the administration
of acrylonitrile. At a higher dose (65 mg/kg/day), the increase in
malformations was statistically significant, and the same malformations
were seen at both doses. Statistically significant lowered fetal body
weight and shorter crown-rump length also were observed at 65 mg/kg/day.
The number of live pups and resorption per litter were not affected by
the administration of acrylonitrile. In this study a NOAEL of
10 mg/kg/day was established. Based on this value an acute oral MRL of
0.1 mg/kg/day was calculated as described in the footnote in Table 2-2.
The highest NOAEL values and all reliable LOAEL values for
developmental effects in each species and duration category are recorded
in Table 2-2 and plotted in Figure 2-2. 
2.2.2.6 Reproductive Effects 
In a three-generation reproduction study in rats, Beliles et al. 
(1980) found that exposure of animals to acrylonitrile in drinking water
at 70 mg/kg/day resulted in reduced viability and lactation indices in
all generations. The authors considered the reduced pup indices to be
the result of maternal toxicity, possibly related to reduced milk
production due to decreased water intake by the dams. Fostering of pups
on untreated dams lessened pup mortality. Measurement of acrylonitrile
in the pups was not performed. 
Animal studies suggest possible effects of acrylonitrile on the
male reproductive system. Tandon et al. (1988) observed histological
and biochemical evidence of degenerative changes in testicular tubules
of mice exposed to 10 mg/kg/day of acrylonitrile for 60 days. These
changes were accompanied by a 45% decrease in sperm count. Whether the
tubular changes or the decreased sperm count have an effect on fertility
is not known because no studies have been conducted to evaluate the 
effects of acrylonitrile on the reproductive capability of treated mice.
Based on the reduced sperm count and the degenerative changes in
testicular tubules, an intermediate oral MRL of 0.01 mg/kg/day was
calculated as described in the footnote in Table 2-2. 
There appear to be significant inter-species differences with
respect to histopathological effects of acrylonitrile on the male
reproductive system. Histological examination did not reveal testicular
degeneration in rats or dogs given acrylonitrile for 2 years
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an increase in testicular weight was observed in rats given
acrylonitrile in drinking water at doses of 14 mg/kg/day for 2 years
(Bio/dynamics 1980a). The biological significance of this effect is not
clear, because this was observed in only one chronic drinking water
study in rats, and was not observed in a gavage study in the same strain
of rat (Spartan) or at comparable doses in Fisher 344 rats (Bio/dynamics
1980b, 1980c). 
The highest NOAEL values and all reliable LOAEL values for
reproductive effects in each species and duration category are recorded
in Table 2-2 and plotted in Figure 2-2. 
2.2.2.7 Genotoxic Effects 
In vivo studies in animals suggest that oral exposure to acrylonitrile
has limited genotoxic potential. Acrylonitrile produced no
significant increase in chromosomal aberrations in bone marrow cells
from rats administered up to 21 mg/kg/day (Rabello-Gay and Ahmed 1980),
and no significant effect in a dominant lethal assay in rats at doses up
to 60 mg/kg/day (Working et al. 1987). Studies on unscheduled DNA
synthesis in liver and brain of rats exposed to doses of 50 mg/kg showed
increased DNA synthesis in the liver but not in the brain, suggesting
limited potential for acrylonitrile to be genotoxic (Hogy and Guengerich
1986). However, unscheduled DNA synthesis was not observed in an
in vivo spermatocyte assay in rats exposed to 60 mg/kg/day (Hurtt et al.
1987). 
2.2.2.8 Cancer 
No studies were located regarding cancer in humans following oral
exposure to acrylonitrile. 
Chronic studies in rats provide convincing evidence that
acrylonitrile is carcinogenic to animals when administered orally
(Beliles et al. 1980; Bigner et al. 1986; Bio/dynamics 1980a, 1980b,
198Oc; Gallagher et al. 1988; Quast et al. 1980a). Tumors of the
central nervous system and Zymbal gland were identified in most studies
at doses of 1.4 mg/kg/day and higher. Tumors of the gastrointestinal
tract (forestomach, intestines) and mammary gland (in females) were also
common at doses of 3.4 mg/kg/day or higher (Bigner et al. 1986;
Bio/dynamics 1980a, 198Oc; Maltoni et al. 1977; Quast et al. 1980b).
Gallagher et al. (1988) noted a dose-dependent decrease in the number of
rats with pituitary tumors (mainly prolactinomas) following chronic oral
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2.2.3 Dermal Exposure 
2.2.3.1 Death 
The death of a 10-year-old girl following dermal exposure to
acrylonitrile was reported by Lorz (1950). An acrylonitrile preparation
had been applied to the scalp of the child as a treatment for head lice.
The child experienced nausea, headache and dizziness. Death occurred
4 hours after application. The concentration was not specified in this
case report. 
In guinea pigs, the dermal LD50 was reported to be 370 mg/kg
(Roudabush et al. 1965). Values of 226 to 250 mg/kg have been noted in
rabbits (Back et al. 1972; Roudabush et al. 1965). 
The highest NOAEL values and all reliable LOAEL values for death in
each species and duration category are recorded in Table 2-3. 
2.2.3.2 Systemic Effects 
No studies were located regarding systemic effects in animals
following dermal exposure to acrylonitrile. 
In humans, one study of a worker accidentally sprayed with
acrylonitrile indicated that transient injury to liver and muscle may
have occurred, but the data are too limited to draw any firm conclusions
(Vogel and Kirkendall 1984). 
Workers exposed to acrylonitrile vapors at 16 to 100 ppm for 20 to
45 minutes complained of intolerable itching of the skin, but no
dermatitis was observed (Wilson et al. 1948). This is presumably a
direct irritant effect of acrylonitrile on the skin. 
In a study of Japanese workers exposed to acrylonitrile, irritation
of the conjunctiva and upper respiratory tract was reported. Workers
who may have been exposed to particularly high concentrations (inside
polymerization tanks) experienced transient irritation of the scrotal
skin. No concentrations of acrylonitrile were specified (Sakurai et al.
1978). 
2.2.3.3 Immunological Effects 
No studies were located regarding immunological effects in humans
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2.2.3.4 Neurological Effects 
Signs of cyanide poisoning were exhibited by a man accidentally
sprayed with acrylonitrile. Dizziness, redness, nausea, vomiting and
hallucinations were reported (Vogel and Kirkendall 1984). The symptoms
persisted for 3 days. 
No studies were located regarding the following health effects in
humans or animals after dermal exposure to acrylonitrile. 
2.2.3.5 Developmental Effects 
2.2.3.6 Reproductive Effects 





In a well-controlled and conducted study with human volunteers,
Jakubowski et al. (1987) reported that an average of 52% of the inhaled
dose of acrylonitrile (5 or 10 mg/m3) is absorbed by the lungs. Similar
results were reported by Rogaczewska and Piotrowski (1968), who found
that 46% of inhaled acrylonitrile is retained by the lungs of humans. 
Pilon et al. (1988b) demonstrated in rats exposed to 4 mg/kg
acrylonitrile (2,3-14C) in a closed-circuit inhalation chamber that the
absorption of acrylonitrile was biphasic, characterized by a rapid dose-
dependent phase that was followed by a slower dose-independent phase. 
2.3.1.2 Oral Exposure 
No studies were located regarding absorption in humans following
oral exposure to acrylonitrile. 
Results of studies in laboratory animals with 14C-acrylonitrile
indicate acrylonitrile is rapidly and extensively absorbed by the oral
route. Radiolabeled acrylonitrile is detected in blood within
30 minutes after administration of an oral dose and peak plasma
concentrations are reached 6 hours after administration (Farooqui and
Ahmed 1982). Extensive absorption is indicated by the fact that only 2
to 10% of administered radioactivity is recovered in the feces (Ahmed
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2.3.1.3 Dermal Exposure 
In studies in human volunteers conducted by Rogaczewska and
Piotrowski (1968), absorption by skin was estimated to be 0.6 mg/cm2/hr.
Though no quantitative estimates of dermal absorption could be made,
absorption of acrylonitrile via the dermal route by humans was
demonstrated in a case study by Vogel and Kirkendall (1984). Accidental
spraying of a man with acrylonitrile resulted in marked symptoms of
acrylonitrile toxicity, indicating that significant amounts of
acrylonitrile had been absorbed, primarily through the skin. 
No studies were located regarding absorption in animals following
dermal exposure to acrylonitrile. 
2.3.2 Distribution 
2.3.2.1 Inhalation Exposure
No studies were located regarding distribution of acrylonitrile in
humans following inhalation exposure to acrylonitrile. 
Acrylonitrile is rapidly distributed throughout the body after
inhalation exposure. Measurable amounts of acrylonitrile derived
radiolabel were present in the brain, stomach, liver, kidney, lung and
blood within 1 hour of initiation of exposure (Pilon et al. 1988b). 
2.3.2.2 Oral Exposure 
Tissue distribution of radioactivity in rats after a single oral
dose of 14C-acrylonitrile indicates that acrylonitrile and its
metabolites are rapidly distributed to all tissues (Ahmed et al. 1982,
1983; Silver et al. 1987; Young et al. 1977). Species differences are
apparent. In mice, cyanide levels in the blood peaked at 1 hour, while
in rats peak levels were not reached until 3 hours after administration
(Ahmed and Pate1 1981). The highest levels of radioactivity were
recovered in the gastrointestinal tract, in particular in the stomach.
The retention of acrylonitrile and its metabolites in the stomach
appears to be due, at least in part, to covalent binding (Ahmed et al.
1982; Silver et al. 1987). Young et al. (1977) noted that label
accumulated in the stomach following intravenous as well as oral
exposure to 14C-acrylonitrile, suggesting that enterogastric circulation
may be important in the preferential retention in the stomach. 
Distribution studies by whole-body autoradiography in rats and
monkeys revealed accumulation of radiolabel in the liver, kidney, lung,
adrenal cortex and stomach. In fetuses exposed in utero, only the eye
lens accumulated radiolabel at a higher concentration than that observed
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2.3.2.3 Dermal Exposure 
No studies were located regarding distribution in humans or animals
following dermal exposure to acrylonitrile. 
2.3.3 Metabolism 
Proposed pathways for the metabolism of acrylonitrile are presented
in Figure 2-3 (Ahmed et al. 1983; EPA 1980a; Langvardt et al. 1980;
Linhart et al. 1988; Muller et al. 1987; Pilon et al. 1988a; Roberts
et al. 1989). Studies indicate that the metabolism of acrylonitrile in
animals proceeds by the same pathways whether exposure is by the oral
(Ahmed et al. 1983; Langvardt et al. 1980; Pilon et al. 1988a) or the
inhalation route (Gut et al. 1985; Muller et al. 1987; Tardif et al.
1987). No data were located regarding the metabolism of acrylonitrile
following dermal exposure. 
Both enzymatic and nonenzymatic biotransformation of acrylonitrile
occurs. Acrylonitrile is capable of covalently binding to proteins and
other macromolecules such as lipids or nucleic acids, or acrylonitrile
can also be directly conjugated to glutathione and excreted in urine as
cyanoethylmercapturic acid. 
Alternatively, acrylonitrile is metabolized to 2-cyanoethylene
oxide by the microsomal enzyme system. 2-Cyanoethylene oxide can react
directly with tissue macromolecules or it can be further metabolized to
oxidation products that release cyanide. Cyanide is converted to
thiocyanate and excreted in the urine. 2-Cyanoethylene oxide is also
conjugated with glutathione and metabolized to 2-hydroxyethylmercapturic
acid which is excreted in the urine. 
Acrylonitrile is also metabolized to CO2 which is eliminated 
through the lungs. Carbon dioxide is produced when acrylonitrile is
metabolized to ethylene oxide and degraded to oxidation products and
cyanide via the epoxide hydratase pathways (Farooqui and Ahmed 1982;
Young et al. 1977). 
Studies indicate that acrylonitrile conjugation with glutathione is
the preferred pathway for metabolism (Ghanayem and Ahmed 1982; Miller
and Villaume 1978; Pilon et al. 1988a). However, if glutathione is
depleted or the pathway is overloaded (as may be the case at high
doses), metabolism to the thiocyanate via 2-cyanoethylene oxide is
increased. Increased thiocyanate excretion with glutathione depletion
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depleted rats excreted 58% of an orally administered dose as
thiocyanate, while normal rats given the same dose (4 mg/kg) of
acrylonitrile excreted only 23% as thiocyanate. Normal rats given
acrylonitrile at 4 or 10 mg/kg excreted 16% and 23% of the dose as
thiocyanate, respectively. 
The increased metabolism of acrylonitrile to 2-cyanoethylene oxide
has significant implications in acrylonitrile toxicity. 2-Cyanoethylene
oxide has been shown to react with cell macromolecules (including
nucleic acids) both in vivo and in vitro (Guengerich et al. 1981; Hogy
and Guengerich 1986). This metabolite may be responsible for the
carcinogenic effects of acrylonitrile. 
Urinary excretion patterns of thiocyanate suggest that there are
quantitative species differences in acrylonitrile metabolism (Ahmed and
Pate1 1981). Thiocyanate was identified as a metabolite in rats, mice,
rabbits and Chinese hamsters. About 20 to 23% of the administered dose 
was excreted as thiocyanate in rats, rabbits and Chinese hamsters, while
35% was excreted as thiocyanate in mice (Gut et al. 1975). It has also
been observed that mice metabolize acrylonitrile more rapidly than rats
(Ahmed and Pate1 1981; Gut et al. 1975). Maximum blood cyanide
concentrations were observed 1 hour after dosing in mice, but 3 hours
after dosing in rats (Ahmed and Pate1 1981). In mice, thiocyanate was
present in the urine within 4 hours of dosing, while in rats,
thiocyanate was present in urine only at time intervals longer than
4 hours (Gut et al, 1975). 
In humans, metabolites of acrylonitrile have been identified in
urine following occupational exposure (assumed to be by the inhalation
route), and also in controlled exposure studies. Metabolites identified
in humans were the same as those in animals (Jakubowski et al. 1987;
Sakurai et al. 1978). Acrylonitrile and thiocyanate were quantified in
urine of workers exposed to acrylonitrile. Dose-related increases in
thiocyanate were observed, indicating that cyanide is liberated with the
metabolism of acrylonitrile. In a study with human volunteers under
controlled conditions, 2-cyanoethylmercapturic acid (CMA) was monitored
in urine as an indication of exposure. On average, 22% of the absorbed
acrylonitrile was metabolized to CMA; however, considerable individual
variability was observed. The CMA excretion ranged from 13% to 39% of
the absorbed dose (Jakubowski et al. 1987). 
In a case study of a human male accidentally sprayed with
acrylonitrile, recurring signs of cyanide poisoning were seen over a
3 day period (Vogel and Kirkendall 1984). This indicates that
acrylonitrile is also metabolized to cyanide following predominantly
dermal exposure. 
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2.3.4 Excretion 
2.3.4.1 Inhalation Exposure 
Studies on workers in an occupational setting showed a dose-
response relationship between the concentration of acrylonitrile of
inspired air and the recovery of metabolites in the urine (Houthuijs
et al. 1982; Sakurai et al. 1978). In a controlled study using human
volunteers, urinary metabolite data suggested that the elimination of
acrylonitrile followed first-order kinetics, with a half-life of seven
to eight hours (Jakubowski et al. 1987). 
The predominant route of excretion in rats is via urine (Gut et al.
1985; Tardif et al. 1987; Young et al. 1977). In rats exposed to 5 ppm
of l-14C-acrylonitrile for 6 hours, 68% of the absorbed radioactivity
was excreted in the urine within 220 hours, with 3.9% in the feces, 6.1%
in expired air as 14C02, and 18% of the radioactivity being retained in
the body tissues. Following exposure to a higher concentration
(100 mm), a larger fraction of the dose was recovered in urine (82%)
and a smaller fraction (2.6%) was retained in the body (Young et al.
1977), indicating that urinary excretion is dose-dependent. Percent
fecal excretion was similar at both doses. 
2.3.4.2 Oral Exposure 
Following oral exposure, the major route of excretion of
acrylonitrile in rats is via the urine, either as thiocyanate or as
other products of conjugation. Within the first 24 hours of a single
oral dose, 40% to 60% was recovered in the urine (Ahmed et al. 1983).
Farooqui and Ahmed (1982) reported that 10 days after the administration
of a single dose, 61% of the dose had been accounted for in the urine,
3% in feces and 13% in the expired air. Approximately 25% was retained
in the body covalently bound to tissues (see Section 2.3.3). 
A study by Young et al. (1977) showed that retention and excretion
of acrylonitrile are not directly proportional to dose. The data
suggest a saturation process, perhaps due to covalent binding to tissue
macromolecules. Seventy-two hours after administration of single oral
doses of either 0.1 or 10 mg/kg, the proportion of the dose retained in
the carcass was 37% at the low dose (0.1 mg/kg) and 27% at the high dose
(10 mg/kg). 
2.3.4.3 Dermal Exposure 
No studies were located regarding excretion in humans or animals
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2.4 RELEVANCE TO PUBLIC HEALTH 
Acrylonitrile is a common industrial chemical, and humans may be
exposed to acrylonitrile around factories where it is made or used, or
near chemical waste sites where it has been improperly stored or
disposed of. The two most likely exposure pathways are breathing
acrylonitrile that has evaporated into air (it is readily volatile), or
drinking water that has been contaminated (acrylonitrile is highly
soluble and stable in water). However, data describing acrylonitrile
levels in drinking water are currently lacking. The low odor threshold
of acrylonitrile in water (19 ppm) could limit exposure to this
substance through contaminated drinking water. 
Short exposures at high concentrations show cyanide-type toxicity.
In humans, symptoms include headaches, feelings of nausea, irritability,
and apprehension. These symptoms are reversible. However, prolonged
exposure can result in death. Limited data suggest that children may be
more susceptible to acrylonitrile toxicity than adults. However,
current data are not significant to draw firm conclusions. In animals,
acrylonitrile has been shown to result in teratogenic effects when
administered by either the inhalation or oral routes of exposure.
Impaired reproductive capability has also been demonstrated in mice.
Exposures high enough to cause neurological, developmental, or
reproductive effects in humans are rather unlikely to occur except in
cases of spills or accidents. 
Epidemiologic studies have associated acrylonitrile exposure in the
workplace with increased incidence of lung cancer and possibly prostate
cancer. Because only six cases of prostate cancer were observed and all
were found in workers at ages when the incidence rate increases, firm
conclusions cannot be made about the potential for acrylonitrile to
cause prostate cancer. In animals, acrylonitrile has been demonstrated
to cause tumors at multiple sites, including the nervous system,
gastrointestinal tract, Zymbal gland and mammary gland. Because of this
clear carcinogenic potential, chronic low-level exposure to
acrylonitrile is of special concern. 
Death. Several cases of death in children following inhalation or
dermal exposure to acrylonitrile has been reported (Grunske 1949; Lorz
1950). Children seem to be more susceptible to the lethal effect of
acrylonitrile than adults. However, current data are not sufficient to
draw firm conclusions regarding risk. In the case studies where
children had died after sleeping in rooms fumigated with acrylonitrile,
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In animals, deaths from acrylonitrile have been reported in several
species following inhalation, oral or dermal exposure. In most species,
death appears to be related to cyanide poisoning. That the cyanide
moiety is involved in human toxicity of acrylonitrile has been reported
in a case study in which a human male was sprayed with acrylonitrile
when a valve burst (Vogel and Kirkendall 1984). This individual
suffered symptoms characteristic of cyanide poisoning, and treatments
designed to reduce cyanide levels in the blood were required in order to
save his life. 
Systemic Effects. Humans exposed to high levels of acrylonitrile
in the workplace have complained of nasal irritation and an oppressive
feeling in the upper respiratory passages (Wilson 1944; Wilson et al.
1948). Acute exposure of guinea pigs to acrylonitrile has resulted in
severe pulmonary irritation and lung edema. In other species, only mild
pulmonary irritation has been reported (Dudley and Neal 1942). Chronic
exposure to acrylonitrile via inhalation has resulted in degenerative
and inflammatory changes in the nasal passages in rats (Quast et al.
1980a). The concentrations at which these effects have been seen in
animals are irritating to the respiratory tract of humans. 
The gastrointestinal tract does not appear to be a target organ of
acrylonitrile toxicity in humans. In animals, noncarcinogenic lesions
in the esophagus and stomach suggest an irritational effect on the 
gastrointestinal tract (Murray et al. 1978; Quast et al. 1975).
However, several investigators (Cote et al. 1984; Ghanayem and Ahmed
1983; Ghanayem et al. 1985; Szabo et al. 1983) have demonstrated that
gastrointestinal bleeding and duodenal ulcers may occur even when rats
were given acrylonitrile by routes other than oral, suggesting that the
effects on the gastrointestinal tract may not be due exclusively to
irritation. More study is needed in this area before any conclusions
about the relevance to human health can be drawn. 
In humans, severe cases of acrylonitrile poisoning have resulted in
low grade anemia (Wilson 1944; Wilson et al. 1948), but complete
recovery was reported. Chronic occupational exposure to low levels of
acrylonitrile has not resulted in detectable effects on the
hematological system (Sakurai et al. 1978). In intermediate and chronic
studies in animals, decreased red cell count, hemoglobin concentration
and hematocyte were observed (Bio/dynamics 1980a, 1980b, 198Oc; Quast
et al. 1975; 198Oa). However, it is not certain if these effects are
due to acrylonitrile binding to red blood cell membranes and proteins
(Farooqui and Ahmed 1982), or are secondary effects related to the poor
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Some liver damage has been reported in humans after acute exposure
to high doses. In workers exposed to high levels of acrylonitrile
vapors, mild jaundice was diagnosed (Wilson 1944). In a case of an
accidental dermal exposure of a man, enzyme levels in the blood
suggestive of liver injury were reported for several days (Vogel and
Kirkendall 1984). These effects appeared to be fully reversible. 
The liver has been reported to be the primary site of acrylonitrile
metabolism. Metabolism studies indicate that a toxic metabolite 
(2-cyanoethylene oxide) is formed that covalently binds to liver tissue.
However, the liver has not been indicated as a target organ for
intermediate or chronic exposure in humans or animals. In factory
workers exposed to acrylonitrile for 10 or more years, no liver damage
has been observed (Sakurai et al. 1978). In animal studies, microscopic
examination of liver tissue has revealed no hepatic damage after 90 days
to 2 years of exposure by the inhalation or oral routes (Bio/dynamics
1980a, 1980b, 198Oc; Humiston et al. 1975; Quast 1975, 1980a, 1980b). 
Some effects seen in the livers of animals may suggest that
adaptive changes occur as a response to increased metabolic activity.
These include increased glutathione levels, possibly due to an increased
demand for glutathione for the metabolism of acrylonitrile. Increased
liver weights have also been observed in both acute and chronic oral
studies (Bio/dynamics 1980a, 1980b, 198Oc; Murray et al. 1978). 
Skin irritation results from direct contact with liquid or gaseous
acrylonitrile. Workers exposed to high levels of acrylonitrile in air
have complained of itching, but no dermatitis was observed (Wilson
et al. 1948). Also, transient irritation of scrotal skin has been noted
by workers after entering areas with high ambient acrylonitrile
concentrations. Direct contact of acrylonitrile with the skin has
resulted in erythema, desquamation and slow healing (Dudley and Neal
1942). In both humans and animals, skin redness has been reported
subsequent to acute exposures (Dudley and Neal 1942; Vogel and
Kirkendall 1984). 
Immunological Effects. Immunological effects of acrylonitrile have
not been studied in humans or animals. 
Neurological Effects. Acute effects have been described as being a
cyanide-type poisoning (Dudley and Neal 1942; Vogel and Kirkendall
1984). These observations are consistent with results from studies in
animals where it has been shown that the major metabolic pathways
include cyanide and thiocyanate as products of acrylonitrile metabolism
(Ahmed et al. 1983; EPA 1980a; Langvardt et al. 1980; Pilon et al.
1988a). The formation of cyanide following oral exposure is greater
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that the amount of acrylonitrile reaching the liver in free form (i.e.,
not covalently bound) may determine the amount of cyanide formed.
Symptoms which have been associated with acrylonitrile poisoning in
humans include limb weakness, labored and irregular breathing, dizziness
and impaired judgment, cyanosis and nausea, collapse, and convulsions
(Baxter 1979). Case studies of occupational exposure to acrylonitrile
suggest that the acute nonlethal effects in humans may be fully
reversible (Vogel and Kirkendall 1984; Wilson 1944; Wilson et al. 1948). 
Acute exposure of several species of animals has been reported to
lead to convulsions and coma (Dudley and Neal 1942). Exposure of
animals for 6 months or more at 16 mg of acrylonitrile per kilogram body
weight per day (mg/kg/day) results in neurological effects characterized
by decreased activity and depression (Bigner et al. 1986; Beliles et al.
1980; Quast et al. 1975). However, the only histopathological changes
seen in the nervous system have been those associated with the formation
of tumors (Bio/dynamics 1980a, 1980b, 1980c; Quast et al. 1975, 1980a,
1980b). 
Developmental Effects. There are no data available on 
developmental effects of acrylonitrile in humans; however, two well-conducted
studies in rats have shown that acrylonitrile is teratogenic
in animals by both inhalation and oral exposure (Murray et al. 1978).
Fetal malformations occurred in a dose-related manner. When 
administered orally, malformations were present even at doses in which
no maternal or fetal toxicity was apparent. 
Reproductive Effects. There are no data available on the 
reproductive effects in humans. However, a three-generation
reproduction study in rats showed that acrylonitrile has an effect on
reproduction. In all three generations, viability and lactation indices
were affected by 'the presence of acrylonitrile in the drinking water
(Beliles et al. 1980). Species differences were observed with respect
to the effects of acrylonitrile on male reproductive organs. In mice,
adverse effects on male reproductive organs were demonstrated at
10 mg/kg/day in a 60-day study (Tandon et al. 1988). In rats, no
effects on male reproductive organs were seen even when exposure was at
14 mg/kg/day for 2 years (Bio/dynamics 1980a, 1980b, 198Oc; Quast et al.
1980a, 1980b). 
Genotoxic Effects. The genotoxicity of acrylonitrile in vitro has 
been extensively studied (Table 2-4). Although the results are not
entirely consistent, positive results have been observed for all end
points evaluated: gene mutations, chromosomal aberrations, DNA damage,
and cell transformation. However, in vivo genotoxicity studies have
generally been negative in mammalian systems, including humans
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acrylonitrile may have potential for genotoxicity in vivo. 
Acrylonitrile and its metabolites have been shown to bind to nucleic
acids both in vivo and in vitro suggesting that acrylonitrile does have
potential for genetic damage. 
Cancer. Studies in rats by inhalation and oral exposure have all
demonstrated that acrylonitrile is carcinogenic. Multiple tumor sites
have been identified (Bio/dynamics 1980a, 1980b, 1980c; Quast et al.
1980a, 1980b). There is limited evidence that acrylonitrile is a human
carcinogen. Some epidemiology studies indicate that occupational
exposure to acrylonitrile results in an increased incidence of lung
cancer (O'Berg 1980; O'Berg et al. 1985). However, other studies have
not reached this conclusion (Collins et al. 1989; Kiesselbach et al.
1979). There is also a suggestion that acrylonitrile exposure may
result in an increased incidence of prostate cancer (Chen et al. 1987;
O'Berg et al. 1985). Limitations of these studies do not allow firm
conclusions about the potential for acrylonitrile to cause prostate
cancer. EPA has classified acrylonitrile as a probable human carcinogen
(IRIS 1988). There is sufficient evidence in animals that acrylonitrile
is carcinogenic, but the human evidence is limited. 
2.5 BIOMARKERS OF EXPOSURE AND EFFECT 
Biomarkers are broadly defined as indicators signaling events in
biologic systems or samples. They have been classified as biomarkers of
exposure, biomarkers of effect, and biomarkers of susceptibility
(NAS/NRC 1989). 
A biomarker of exposure is a xenobiotic substance or its
metabolite(s) or the product of an interaction between a xenobiotic
agent and some target molecule or cell that is measured within a
compartment of an organism (NAS/NRC 1989). The preferred biomarkers of
exposure are generally the substance itself or substance-specific
metabolites in readily obtainable body fluid or excreta. However,
several factors can confound the use and interpretation of biomarkers of
exposure. The body burden of a substance may be the result of exposures
from more than one source. The substance being measured may be a
metabolite of another xenobiotic (e.g., high urinary levels of phenol
can result from exposure to several different aromatic compounds).
Depending on the properties of the substance (e.g., biologic half-life)
and environmental conditions (e.g., duration and route of exposure), the
substance and all of its metabolites may have left the body by the time
biologic samples can be taken. It may be difficult to identify
individuals exposed to hazardous substances that are commonly found in
body tissues and fluids (e.g., essential mineral nutrients such as
copper, zinc and selenium). Biomarkers of exposure to acrylonitrile are













2. HEALTH EFFECTS 
Biomarkers of effect are defined as any measurable biochemical,
physiologic, or other alteration within an organism that, depending on
magnitude, can be recognized as an established or potential health
impairment or disease (NAS/NRC 1989). This definition encompasses
biochemical or cellular signals of tissue dysfunction (e.g., increased
liver enzyme activity or pathologic changes in female genital epithelium
cells), as well as physiologic signs of dysfunction such as increased
blood pressure or decreased lung capacity. Note that these markers are
often not substance specific. They also may not be directly adverse,
but can indicate potential health impairment (e.g., DNA adducts).
Biomarkers of effects caused by acrylonitrile are discussed in
Section 2.5.2. 
A biomarker of susceptibility is an indicator of an inherent or
acquired limitation of an organism's ability to respond to the challenge
of exposure to a specific xenobiotic. It can be an intrinsic genetic or
other characteristic or a preexisting disease that results in an
increase in absorbed dose, biologically effective dose, or target tissue
response. If biomarkers of susceptibility exist, they are discussed in
Section 2.7, "POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE." 
2.5.1 Biomarkers Used to Identify and/or Quantify Exposure to
Acrylonitrile
Parent acrylonitrile molecule and its metabolites have been
measured in blood and urine, but, except for measurement of thiocyanate,
methods have not been developed for routine monitoring of exposed
humans. 
Factory workers exposed to an average of 0.1, 0.5 and 4.2 ppm of
acrylonitrile in the air during an 8-hour work day averaged 3.9, 19.7,
and 360 µg/L acrylonitrile in the urine, respectively, and 4.5, 5.78,
and 11.4 mg/L thiocyanate in the urine, respectively (Sakurai et al.
1978). No acrylonitrile was detected in the urine of a control group,
but an average of 4.00 mg/L of thiocyanate was found in the urine. The
presence of thiocyanate in the urine of workers not exposed to
acrylonitrile has been related to cigarette smoking (Houthuijs et al.
1882; Sakuria et al. 1978). Houthuijs et al. (1982) reported post-shift
acrylonitrile values of 39 µg/L when the mean acrylonitrile
concentration in the air was 0.13 ppm. 
2.5.2 Biomarkers Used to Characterize Effects Caused by Acrylonitrile 
A variety of effects have been demonstrated following acrylonitrile
exposure in humans and animals. These effects show a close similarity
to an underlying cyanide effect, particularly for acute exposures.















2. HEALTH EFFECTS 
signs and symptoms such as increased salivation, dizziness, and labored
and irregular breathing. In some cases convulsions and coma may occur.
Because the release of cyanide for producing toxic effects is common for
other compounds, measuring these effects is not specific for
acrylonitrile exposure. These effects do identify potential health
impairment. It should be noted that the toxicity of acrylonitrile
resides not only in the cyanide radical but in the entire molecule. The
latter structure explains various chronic effects such as cancer that
result from acrylonitrile, as opposed to cyanide whose effects are more
relevant for acute toxicity. Studies that identify subtle physiological
changes that can be used to detect or predict risk of disease following
long-term exposure to acrylonitrile are not available. 
2.6 INTERACTIONS WITH OTHER CHEMICALS 
The interaction between acrylonitrile and other chemicals has not
been thoroughly studied. O'Berg (1980) noted that out of 8 workers
exposed to acrylonitrile who developed lung cancer, 7 were smokers
(smoking history was not available for the eighth individual). This
suggests that smoking might increase lung cancer risk from
acrylonitrile, but the data are too limited to draw any firm conclusions
on this point. 
Radimer et al. (1974) described four cases of severe epidermal
necrolysis in individuals who had been exposed to the residual fumes of
a mixture of acrylonitrile and carbon tetrachloride used to fumigate
their homes. Three of the people died. The authors thought this was
most likely due to the effects of acrylonitrile, but noted that an
interaction between carbon tetrachloride and acrylonitrile was possible. 
In animals, the hemorrhagic effects of acrylonitrile exposure on
the adrenals may be reduced by prior exposure of the animals to
adrenergic blockers or chemicals that deplete the adrenal cortex of
catecholamines (Silver et al. 1987; Szabo et al. 1980). It is difficult
to judge whether adrenergic antagonists would have a similar protective
effect in humans, because effects of acrylonitrile on the adrenal have
not been described in humans. 
Acrylonitrile alone has little tendency to produce duodenal ulcers
in animals, but pretreatment with phenobarbital or Aroclor results in a
marked increase in the incidence of such ulcers (Szabo et al. 1983,
1984). Although the mechanism of the ulcerogenic effect is not obvious,
these data indicate that agents which enhanced mixed-function oxidase
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2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
Case studies of acrylonitrile poisoning in humans following
fumigation of living quarters in post-World War II Germany suggest that
children are more susceptible to acrylonitrile than adults (Grunske
1949). Children died after sleeping in rooms recently fumigated with
acrylonitrile for lice and bed bugs, while adults sharing the same
quarters reported few, if any, effects (skin or eye irritation). 
Studies in animals indicate that acrylonitrile can produce
teratogenic effects at doses that have little maternal toxicity,
suggesting that pregnant women may also be susceptible. It also seems
likely that individuals in poor health or with respiratory problems
might be particularly susceptible to acrylonitrile, but there are no
data on this point. 
2.8 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of
the Public Health Service) to assess whether adequate information on the
health effects of acrylonitrile is available. Where adequate
information is not available, ATSDR, in conjunction with the National
Toxicology Program (NTP), is required to assure the initiation of a
program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of
acrylonitrile. 
The following categories of possible data needs have been
identified by a joint team of scientists from ATSDR, NTP, and EPA. They
are defined as substance-specific informational needs that, if met would
reduce or eliminate the uncertainties of human health assessment. In 
the future, the identified data needs will be evaluated and prioritized,
and a substance-specific research agenda will be proposed. 
2.8.1 Existing Information on the Health Effects of Acrylonitrile 
Figure 2-4 summarizes areas concerning the health effects of
acrylonitrile where studies have and have not been performed. There are
some data available on the effects in humans following acute or chronic
exposure to acrylonitrile via the inhalation route of exposure. The
target organ for acute toxicity is the nervous system. Chronic exposure
to acrylonitrile has been associated with cancer. However, many of the
available reports lack quantitative information on exposure levels. In
humans, there are no data on oral exposure to acrylonitrile and a very
limited amount of acute data on dermal exposure. In animals, there are
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2.8.2 Identification of Data Needs 
Acute-Duration Exposure. Information is available regarding the
effects of acute-duration inhalation exposure of humans to acrylonitrile
and the effects are characteristic of cyanide-type toxicity.
Quantitative data are limited but are sufficient to derive an acute
inhalation MRL. Further studies of humans exposed to low levels of
acrylonitrile in the workplace would increase the confidence of the
acute MRL. Studies in animals support and confirm these findings. No
studies are available on the effects of acute-duration oral exposure in
humans; however, exposure to acrylonitrile reveals neurological
disturbances characteristic of cyanide-type toxicity and lethal effects
in rats and mice. Rats also develop birth defects. Animal data are
sufficient to derive an acute oral MRL. Additional studies employing
other species and various dose levels would be useful in confirming
target tissues and determining thresholds for these effects. In humans,
acrylonitrile causes irritation of the skin and eyes. No data are
available on acute dermal exposures in animals. 
Intermediate-Duration Exposure. No information is available on the 
effects of intermediate-duration inhalation, oral, or dermal exposure in
humans or inhalation and dermal exposures in animals. There is
information on intermediate-duration oral exposure in animals. Studies
revealed decreased reproductive indices, decreased sperm count and
tubular degeneration in rats and mice. Blood cell counts were low in
rats and there was evidence of ulcerogenic effects in dogs.
Acrylonitrile was also lethal in dogs. Data in animals were sufficient
to derive an intermediate-duration oral MRL. Further studies in animals 
would be useful in defining threshold for these effects. 
Chronic-Duration Exposure and Cancer. No studies were located 
evaluating chronic effects associated with acrylonitrile exposure in
humans by any route of exposure. There is evidence of hematological
effects and alterations in organ weights (kidney, liver) in rats
following oral exposure. Additional chronic-duration studies in other
species by inhalation and oral exposures would be useful in determining
other target organs and thresholds for these effects. There are studies
of humans chronically exposed to acrylonitrile in workplace air. These
studies link acrylonitrile exposure to lung cancer and it has been
suggested that the chemical may have the potential to cause prostate
cancer. Due to limitations of these studies, firm conclusions cannot be
made. Additional studies providing quantitative exposure data and
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Genotoxicity. Microbiol and mammalian assays are available on the
genotoxic effects of acrylonitrile. Results of in vitro tests 
evaluating gene mutation in prokaryotic and eukaryotic cell types are
variable. Similarly, results were mixed for in vitro mammalian assays
evaluating gene mutation, chromosomal aberration and DNA repair and
damage. In vivo tests evaluating chromosomal aberrations were negative.
Additional investigations evaluating structural and numerical
chromosomal aberrations in humans exposed in the workplace would be
useful in determining the significance of effects found in animal
assays. 
Reproductive Toxicity. No studies have been conducted in humans 
regarding reproductive toxicity of acrylonitrile after inhalation, oral,
or dermal exposure or inhalation and dermal exposures in animals.
Studies in male mice have shown that exposure to acrylonitrile in
drinking water affects sperm count and results in tubular degeneration.
No effects on male reproductive organs have been reported in rats.
Studies to further evaluate the significance of the testicular effects
on reproductive capability in mice and other species would be very
valuable. Studies on reproduction via the inhalation route would be
valuable in determining whether the effects seen in oral studies are
unique to that route of exposure. 
Developmental Toxicity. No information is available on 
developmental effects of acrylonitrile in humans by any route of
exposure. Acrylonitrile is teratogenic and embryotoxic in rats both by
the oral and inhalation routes of exposure. Developmental studies on
other animal species have not been conducted. Because species
differences for acute acrylonitrile toxicity and metabolism have been
demonstrated, additional developmental studies in other species using
various dose leve.ls would be valuable in evaluating the potential for
acrylonitrile to cause developmental effects in humans. Because the
available oral study was conducted by gavage, additional studies are
needed to determine if these effects will occur following ingestion of
drinking water or food. 
Immunotoxicity. No information was found on the immunological
effects of acrylonitrile in humans or animals by any route of exposure.
Because no immunopathological effects have been reported in subchronic
and chronic studies involving multiple species, additional studies
employing a more specific testing battery are not warranted at this
time. 
Neurotoxicity. Clinical signs indicative of disturbances of the
nervous system in exposed humans have been well documented in short-term
studies at high doses and appear to be reversible. These effects are
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humans. In longer-term studies, effects on the nervous system have also
been reported, but it is not certain if these effects are permanent or
reversible following termination of acrylonitrile exposure. 
Epidemiological and Human Dosimetry Studies. There are studies on 
the adverse effects of acrylonitrile in humans. These studies link
acrylonitrile exposure and lung cancer. It has also been suggested that
acrylonitrile may have the potential to cause prostate cancer. Many of
the studies have major limitations including insufficient quantification
of exposure, short follow-up, small study population, and inadequate
evaluation of confounding associations. Additional studies would be
useful in clarifying the cancer risk and estimating the exposure levels
that lead to these effects. 
Biomarkers of Exposure and Effect. The presence of thiocyanate and
2-cyanoethyl mercapturic acid have been monitored in urine as indicators
of acrylonitrile exposure. 
Effects produced by exposure to acrylonitrile, particularly after
acute exposures, are characteristic of cyanide toxicity. These effects
can be detected in people exposed by evaluating signs and symptoms such
as limb weakness, labored and irregular breathing, dizziness and
impaired judgement, cyanosis and convulsions. While tests are not
specific for acrylonitrile-induced toxicity, they do identify potential
health impairment. Studies to develop more specific biomarkers of
acrylonitrile-induced effects would be useful in assessing the potential
health risk of acrylonitrile near hazardous waste sites. 
Absorption, Distribution, Metabolism, and Excretion. Metabolism 
and excretion in animals exposed to acrylonitrile by the inhalation and
oral routes have been studied extensively. However, only limited data
on absorption and distribution are available. Some data on humans
exposed by inhalation are available. No data are available on the
toxicokinetics of acrylonitrile when the exposure route is dermal. More
extensive information on absorption and distribution of acrylonitrile
would be valuable to fully understand the toxicokinetics of
acrylonitrile. Some data on the toxicokinetics of acrylonitrile by the
dermal route would be valuable in order to determine if metabolism of 
acrylonitrile differs by route of exposure. Development of
physiologically-based toxicokinetic models would also be valuable in
extrapolation of animal data to humans. 
Comparative Toxicokinetics. The absorption, distribution,
metabolism, and excretion of acrylonitrile in rats has been studied.
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differences do exist. Further evaluation of these differences, and
comparison of metabolic patterns in humans with those of animals would
assist in determining the most appropriate animal species for evaluating
the hazard and risk of human exposure to acrylonitrile. 
2.8.3 On-going Studies 
A number of research projects in progress are investigating the
mechanism of toxicity and tumor formation of acrylonitrile. The
projects are summarized in Table 2-6. 
A number of on-going epidemiology studies are evaluating the
effects of occupational exposure to acrylonitrile. Independent
investigations are being conducted by Dr. R. D. Jones of the Employment
Medical Advisory Service of the United Kingdom; Dr. L.J. Lucas of



















































































4. PRODUCTION, IMPORT, USE, AND DISPOSAL 
4.1 PRODUCTION 
Acrylonitrile is produced commercially by the process of propylene
ammoxidation, in which propylene, ammonia and air are reacted in a
fluidized bed in the presence of a catalyst (EPA 1984, 1985a).
Production in the United States has increased gradually over the past
20 years from 304,300 kkga in 1967 (Cogswell 1984) to 1,112,754 kkg in
1987 (USITC 1988). 
Acrylonitrile is currently produced by five manufacturers at six
locations in the United States: American Cyanamid Company, Avondale,
Louisiana; BP America, Inc., Green Lake, Texas and Lima, Ohio; E.I.
duPont de Nemours and Company, Inc., Beaumont, Texas; Monsanto Company,
Chocolate Bayou, Texas; and Sterling Chemicals, Inc., Texas City, Texas
(SRI 1988). 
4.2 IMPORT 
Imports of acrylonitrile have been relatively small. In recent
years, imports of acrylonitrile have decreased from a high of 7,000 kkg
in 1974 to negligible level in 1981 and thereafter. 
A substantial fraction of the acrylonitrile produced in the United
States is exported. Exports rose from 23,500 kkg in 1972 to 364,000 kkg
(39% of United States production) in 1982 (Cogswell 1984). 
4.3 USE 
The primary use of acrylonitrile is as the raw material for the
manufacture of acrylic and modacrylic fibers. Other major uses include
the production of plastics (acrylonitrile-butadiene-styrene (ABS) and
styrene-acrylonitrile (SAN)), nitrile rubbers, nitrile barrier resins,
adiponitrile and acrylamide (EPA 1984). 
Acrylonitrile has been used, in a mixture with carbon
tetrachloride, as a fumigant for flour milling and bakery food
processing equipment and for stored tobacco. However, most pesticide
products containing acrylonitrile have been voluntarily withdrawn by
the manufacturers (IARC 1979). Currently, acrylonitrile in combination
with carbon tetrachloride is registered as a restricted-use pesticide. 









4. PRODUCTION, IMPORT, USE, AND DISPOSAL 
In 1982, 51% of the United States consumption of acrylonitrile was
used for acrylic fibers, 18% for ABS and SAN resins, 14% for
adiponitrile, 5% for acrylamide and 3% for nitrile elastomers. The
remaining 9% was for miscellaneous uses (Cogswell 1984). 
4.4 DISPOSAL 
Because acrylonitrile is listed as a hazardous substance, disposal
of waste acrylonitrile is controlled by a number of federal regulations
(see Chapter 7). Rotary kiln, fluidized bed and liquid injection
incineration are acceptable methods of acrylonitrile disposal (HSDB
1988). Underground injection is another disposal method. The most
recent quantitative information on amount of acrylonitrile disposed in
waste sites is for 1987. Emissions were 0.9 metric tons in surface 
water, 152 metric tons disposed through Publically Owned Treatment Works
(POTW), 92 metric tons disposed of on land and 1,912 metric tons by
underground injection (TRI 1988). Because acrylonitrile is relatively
volatile and is also readily soluble in water, release to the














5. POTENTIAL FOR HUMAN EXPOSURE 
5.1 OVERVIEW 
Humans may be exposed to acrylonitrile through air, water and food.
Acrylonitrile has been identified in 3 of 1,177 NPL sites. The
frequency of these sites within the United States can be seen in
Figure 5-l. 
Acrylonitrile is readily volatile, and significant quantities
escape into air during manufacture and use. Volatilization may also
occur from hazardous waste sites. In air, acrylonitrile is degraded
primarily by reaction with hydroxyl radicals, with an estimated half-
life of 5 to 50 hours. Acrylonitrile has been detected in air in the
vicinity of various industrial sources at concentrations from 0.1 to
325 ppb, but has not been detected in typical ambient air. 
Acrylonitrile is also readily soluble in water, and current total
discharges to water via industrial effluents are low. Water
contamination may also occur following a spill or near a chemical site.
In water, acrylonitrile has little tendency to adsorb to sediment, but
is subject to biodegradation by microorganisms. The rate and extent of
degradation depend upon conditions and upon the time for Microbiol
acclimation. Degradation may approach 100% under favorable circumstances,
but may be inhibited by high concentrations of acrylonitrile. 
For members of the general public who do not live near an
industrial source or a chemical waste site, exposure to very low levels
of acrylonitrile may occur though contact with consumer products such as
acrylic carpeting or by ingestion of food stored in acrylic plastic
containers. Acrylonitrile may enter human food materials by leaching
from plastic food containers. For people who do live near such a
source, inhalation of acrylonitrile in air is likely to be the main
route of exposure, although intake through water could also be of
concern. Inhalation of acrylonitrile in air may be much higher for
workers in industries that produce or use acrylonitrile. Acrylonitrile
has been detected in surface water and groundwater near some industrial
sources and hazardous waste sites, usually at concentrations between 20
and 4,700 ppb. 
5.2 RELEASES TO THE ENVIRONMENT 
5.2.1 Air 
Because acrylonitrile is readily volatile, significant releases to
air may occur during acrylonitrile production and use (Hughes and Horn
1977; Miller and Villaume 1978). Kayser et al. (1982) estimated that
11,790 kkg/yr (metric tons per year) of acrylonitrile was released from
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environment. Quantitative data on air releases from other sources were
not located, but volatilization might be significant following a spill
or in the vicinity of a chemical waste site containing acrylonitrile. 
5.2.2 Water 
Acrylonitrile may also be released to water during production and
use. According to data collected under SARA 313, total reported
releases to water during 1987 were 0.9 metric tons (TRI 1988). No data
were located on acrylonitrile releases to water from other sources, but
because acrylonitrile is readily soluble and is not strongly adsorbed to
soil or sediment (see Section 5.3.1 below), large accidental spills or
leaks from chemical waste sites could lead to significant water
contamination. While acrylonitrile is rapidly biodegraded in water,
high concentrations may inhibit degradation. Several examples of
groundwater contamination following spills have been reported (Miller
and Villaume 1978). Acrylonitrile may also be released to water by
leaks or emissions from hazardous waste sites. Acrylonitrile has been
detected in surface water at 2 sites and in groundwater at 5 sites of
862 hazardous waste sites (including NPL and other sites) being
investigated under Superfund (CLPSD 1988). 
5.2.3 Soil 
Direct release of acrylonitrile to soil during acrylonitrile
production and use is believed to be minimal (less than 1 kkg/yr)
(Kayser et al. 1982). Accidental spills or leaks from hazardous waste
sites could lead to local areas of soil contamination, and acrylonitrile
has been detected in soil at 3 chemical waste sites (NPL and other
sites) being investigated under Superfund (CLPSD 1988). 
5.3 ENVIRONMENTAL FATE 
5.3.1 Transport and Partitioning 
Acrylonitrile is both readily volatile in air (0.13 atm at 23°C)
(Mabey et al. 1982) and highly soluble in water (79,000 mg/L) (Klein
et al. 1957). These characteristics dominate the behavior of
acrylonitrile in the environment. While present in air, acrylonitrile
has little tendency to adsorb to particulate matter (Cupitt 1980), so
air transport of volatilized material is determined mainly by wind speed
and direction. Similarly, acrylonitrile dissolved in water has only a
low tendency to adsorb to suspended soils or sediments (Roy and Griffin
1985), so surface transport is determined by water flow parameters.
Based on its relatively high water solubility, acrylonitrile is expected
to be highly mobile in moist soils. In addition, acrylonitrile may 
76
 
5. POTENTIAL FOR HUMAN EXPOSURE 
penetrate into groundwater from surface spills or from contaminated
surface water. The high vapor pressure indicates that evaporation from
dry soil samples is expected to occur rapidly (EPA 1987). 
The tendency of acrylonitrile to partition between air and water is
described by Henry's law constant (H). The value of H for acrylonitrile
has not been determined experimentally, but has been calculated to be
8.8 x 10-5 atm-m3/mole (Mabey et al. 1982). This value indicates that
acrylonitrile will occur in both air and water, tending to transfer
between air and water phases only slowly. Cupitt (1980) estimated the
half-time of acrylonitrile clearance from air in wet precipitation to be
greater than 10 months. 
Based on the relatively low value of the octanol/water partition
coefficient (Kow) for acrylonitrile (log Kow = -0.92) (Verschueren 1983),
it would not be expected that acrylonitrile will strongly bioaccumulate
in the tissues of aquatic organisms (Kenaga 1980; Neely et al. 1974).
However, data in aquatic organisms exposed to water containing
acrylonitrile show that it does accumulate in fat tissue. Barrows
et al. (1978) measured a steady-state bioconcentration factor (BCF) of
48 in bluegill sunfish. Based on the relative proportion of fat in
sunfish and other aquatic organisms, EPA (1980a) estimated an average
BCF of about 30 for the edible portions of freshwater and marine
species. 
5.3.2 Transformation and Degradation 
5.3.2.1 Air 
The principal pathway leading to degradation of acrylonitrile in
air is believed to be photooxidation, mainly by reaction with hydroxyl
radicals (OH). The rate constant for acrylonitrile reaction with OH
has been measured as 4.1 x 10-l2 cm3/molecule/second (Harris et al.
1981). This would correspond to an atmospheric half-life of about 5 to
50 hours. This is consistent with a value of 9 to 10 hours measured in 
a smog chamber (Suta 1979). 
The photooxidation of acrylonitrile by hydroxyl radicals in the
presence of nitric oxide has been observed to yield formaldehyde (HCHO)
and formyl cyanide (HCOCN) (Hashimoto et al. 1984). From these results,
the following reaction was proposed: 
OH + CH2CHCN + 2N0 + 202 --> HCHO + HCOCN + 2N02 + OH. 
Data given by Hashimoto et al. (1984) suggest that the half-life of
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Acrylonitrile may also be oxidized by other atmospheric components
such as ozone and oxygen, but the rates of these reactions are much
lower than for OH. and are not considered to be an important degradative
pathway (Harris et al. 1981). 
5.3.2.2 Water 
Very little is known about nonbiologically mediated transformations
of acrylonitrile in water. There are no data to suggest that
acrylonitrile hydrolyzes under ambient conditions. While it is known
that acrylonitrile photooxidizes in air, no reliable information was
found on photochemical reactions in water. There were also no data on
the oxidation of acrylonitrile in water. Acrylonitrile is susceptible
to oxidation by strong oxidants such as chlorine used to disinfect
drinking water. 
Acrylonitrile is readily degraded by aerobic microorganisms in
water, especially if there is time for acclimation (Cherry et al. 1956;
Mills and Stack 1953, 1955; Stover and Kincannon 1983). After 27 days
of acclimation, about 70% of the acrylonitrile initially present in
river water was degraded under laboratory conditions, yielding acrylic
acid and ammonia. Complete degradation occurred under ideal conditions
where nutrients were added to promote Microbiol growth (Cherry et al.
1956). 
A bacterium classified as Nocardia rhodochrous LL 100-2 has been 
reported to be able to degrade acrylonitrile (DiGeronimo and Antoine
1976). An aerobic bacterium classified as Arthrobacter in an acclimated
sludge decompletely degraded acrylonitrile after 48 hours yielding
acrylic acid (Yamada et al. 1979). It was proposed that acrylonitrile
was biodegraded by the following reaction: 
CH2CHCN + H20 --> CH2CHCONH2 + H20 --> CH2CHCOOH + NH3 
It has been shown that low concentrations of acrylonitrile in
solution (10 mg/L or less) can be completely degraded in a laboratory,
static-culture batch experiment where domestic sewage water was the
source of the Microbiol inoculum (Tabak et al. 1981). A solution of
acrylonitrile (152 mg/L) was degraded to less than 0.05 mg/L in a
continuous flow activated sludge system under laboratory conditions
(Kincannon et al. 1983). 
Studies performed using sewage sludge indicate that acrylonitrile
may also be degraded by methanogenic bacteria under anaerobic
conditions, although concentrations of 50 to 1,000 mg/L lead to moderate
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suggests that Microbiol degradation of acrylonitrile in anaerobic
groundwater may not proceed efficiently if acrylonitrile levels were
high, as might occur after a spill. 
5.3.2.3 Soil 
No studies were located regarding the biodegradation of
acrylonitrile in soil. However, it seems likely that acrylonitrile in
moist soil would be subject to biodegradation similar to that observed
in aerobic water, although degradation rates might differ. 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
5.4.1 Air 
Acrylonitrile has not been found to occur at measurable
concentrations in ambient air (Brodzinsky and Singh 1983). Measurable
levels of atmospheric acrylonitrile are associated with industrial
sources. 
Air samples collected in one acrylonitrile-fiber plant ranged from
3 to 20 mg/m3 (EPA 1980a). Mean 24-hour acrylonitrile concentrations in
atmospheric samples collected within 5 km of 11 factories producing or
using acrylonitrile ranged from less than 0.1 to 325 µg/m3 (Suta 1979).
The occurrence of acrylonitrile was correlated to wind patterns; the
highest concentrations were downwind of and in close proximity to the
plant. The median concentration of acrylonitrile for 43 measurements in
"source-dominated areas" (i.e., near chemical plants) was 2.1 µg/m3 
(Brodzinsky and Singh 1983). There were no data available on the
concentration of acrylonitrile in air near chemical waste sites, but
because acrylonitrile is easily volatilized, this is an exposure pathway
of concern. 
5.4.2 Water 
Acrylonitrile is not a common contaminant of typical surface water
or groundwater. In a state-wide survey of over 1,700 wells in
Wisconsin, acrylonitrile was not detected in any sample (Krill and
Sonzogni 1986). Acrylonitrile was detected in 46 of 914 samples of
surface water and groundwater taken across the United States (Staples
et al. 1985), generally at levels less than 10 ppb. 
The most likely source of acrylonitrile in water is industrial
discharges. Levels of acrylonitrile measured in the effluents from a
variety of industrial sites (iron and steel factories, textile mills,
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concentrations in nearby rivers ranging from below detection limits to
4,300 ppb (EPA 1983c). Data collected under SARA indicated total
discharges to water during 1987 were 0.9 metric tons (TRI 1988). 
Another source of acrylonitrile in water is leachate from chemical
waste sites. Preliminary data from the Contact Laboratory Program (CLP)
Statistical Database indicates that acrylonitrile has been detected in
surface water samples collected at two of 862 hazardous-waste sites
(including NPL and other sites) being investigated under Superfund. The
median concentration of the positive samples was 100 µg/L (CLPSD 1988).
Acrylonitrile was detected in 12 groundwater samples collected at
5 sites, also at a median concentration of 100 µg/L. 
5.4.3 Soil 
Staples et al. (1985) reported that acrylonitrile was not present
at detectable concentrations in 351 sediment samples collected from lake
and river bottoms across the United States. Preliminary data from the
Contract Laboratory Program (CLP) Statistical Database (CLPSD 1988)
indicated that acrylonitrile was detected in soils at 3 of 862 hazardous
waste sites (including NPL and other sites) being investigated under
Superfund. The median concentration of five samples was 120 µg/kg. 
5.4.4 Other Media 
Foods may become contaminated with acrylonitrile as a result of the
migration of the monomer from chemical containers made of acrylonitrile
polymers. Acrylonitrile has been found to desorb from polyacrylonitrile
resins and partition into cooking oil (Gilbert et al. 1980). Other
foods which may be contaminated by acrylonitrile from their containers
include luncheon meat, peanut butter, margarine, fruit juice, and
vegetable oil (EPA 1980a, 1983c; FDA 1984). There are few data on the
extent of food-related acrylonitrile exposure. The FDA reported typical
acrylonitrile concentrations in margarine of 25 µg/kg (FDA 1984), and
the Commission of European Communities (1983) reported that the levels
of acrylonitrile in contaminated foods are generally about 1 µg/kg.
While past data suggest potential exposure, there is little current
migration of the monomer from current packaging materials because food
is packaged in vastly different resins that have been drastically
improved (AN Group 1990). 
Acrylonitrile was detected in the smoke of cigarettes made in the
United States in the 1960s and 197Os, usually at levels of 1 to 2 mg per
cigarette (IARC 1979). At that time, acrylonitrile was used as a
fumigant for stored tobacco. Most pesticide registrations for
acrylonitrile were cancelled in 1978, and the use of acrylonitrile as a 
80
 
5. POTENTIAL FOR HUMAN EXPOSURE 
fumigant has been discontinued. Although no data were located,
cigarette smoking is probably no longer a major source of human exposure
to acrylonitrile. 
Residual acrylonitrile monomer may also occur in commercially-made
polymeric materials used in rugs and other products. Estimated levels
include acrylic and modacrylic fibers (less than 1 mg acrylonitrile/kg
polymeric material), acrylonitrile-based resins (15 to 50 mg/kg), and
nitrile rubber and latex (0 to 750 mg/kg) (IARC 1979; Miller and
Villaume 1978). It is possible that acrylonitrile may evaporate into
air or leach into water from these products, but no data on this topic
were located. 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
As shown in Table 5-1, only people living near chemical factories
or work sites are likely to be exposed to measurable amounts of
acrylonitrile in air and water. Dispersion modeling studies have
indicated that approximately 2.6 million people living within 30 km of
emission sources may be exposed to atmospheric acrylonitrile (Suta
1979). Members of the general population may also be potentially
exposed to acrylonitrile through the consumption of acrylonitrile-contaminated
food. However, it should be recalled that only foods in
direct contact with acrylonitrile-based plastics are subject to
contamination, and then only at very low levels. 
Occupational exposures via inhalation of acrylonitrile vapor at the
work place are likely to be considerably greater than exposures outside
the workplace (Table 5-l). Exposure levels may be highest for workers
in plants where the chemical is synthesized (EPA 1984). 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
It has been estimated that over 100,000 workers are potentially
exposed to acrylonitrile during production and use (NIOSH 1977, 1988).
Occupational exposures include plastic and polymer manufacturers,
polymer molders, polymer combustion workers, furniture makers, and
manufacturers of fibers and synthetic rubber (EPA 1980a). Other
populations who could have elevated exposure to acrylonitrile are
residents in the vicinity of industrial sources or chemical waste sites. 
5.7 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of
the Public Health Service) to assess whether adequate information on the
health effects of acrylonitrile is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is 

82 
5. POTENTIAL FOR HUMAN EXPOSURE 
required to assure the initiation of a program of research designed to
determine the health effects (and techniques for developing methods to
determine such health effects) of acrylonitrile. 
The following categories of possible data needs have been
identified by a joint team of scientists from ATSDR, NTP, and EPA. They
are defined as substance-specific informational needs that, if met would
reduce or eliminate the uncertainties of human health assessment. In 
the future, the identified data needs will be evaluated and prioritized,
and a substance-specific research agenda will be proposed. 
5.7.1 Identification of Data Needs 
Physical and Chemical Properties. Most of the important physical-chemical
properties of acrylonitrile have been determined (see
Chapter 3). However, the partitioning of acrylonitrile between the air
and water has been evaluated by using an estimated value for a Henry's
law constant. This general approach assumes that the concentration of
the chemical in water is low. Because acrylonitrile is relatively
soluble in water, this approach may not be accurate. Experimental
measurement of the partition coefficient for acrylonitrile at water-air
interfaces would be useful in refining models on the behavior of
acrylonitrile in the environment. 
Production, Use, Release and Disposal. Substantial data exist on 
past production, use and emissions of acrylonitrile in the United
States. Data on current releases to the environment and disposal
practices are collected under SARA 313. Additional studies are not
needed at this time because these data are readily available. 
According to. the Emergency Planning and Community Right to Know Act
of 1986 (EPCRTKA), (§313), (Pub. L. 99-499, Title III, (§313), industries
are required to submit release information to the EPA. The Toxic
Release Inventory (TRI), which contains release information for 1987 and
1988, became available in May of 1989. This database will be updated
yearly and should provide a more reliable estimate of industrial
production and emission. 
Environmental Fate. Laboratory studies indicate that acrylonitrile
is biodegraded in aqueous systems promoting microbial growth, but
typical degradation rates in lakes or rivers have not been studied in
detail. Similarly, it is not known if acrylonitrile will biodegrade
significantly in soil. Data on the chemical oxidation,
photodegradation, and biodegradation of acrylonitrile in surface and
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Bioavailability from Environmental Media. There are limited data 
on the bioavailability of acrylonitrile in different environmental
media. Data on the bioavailability of acrylonitrile would be valuable. 
Food Chain Bioaccumulation. There are no data on the 
bioaccumulation of acrylonitrile in the food chain. The lack of data
may not be a major limitation, because limited data suggest that
acrylonitrile has a relatively low tendency to be bioconcentrated by
lower trophic levels. 
Exposure Levels in Environmental Media. Existing studies have not
provided data on acrylonitrile levels in typical ambient air. Studies
using analytical methods with lower detection limits would be helpful in
determining if ambient air is an exposure medium of concern. Because
higher levels of exposure are most likely near industrial sources or
chemical waste sites, additional data on the occurrence of acrylonitrile
in the atmosphere, surface water, and groundwater near such sites would
be useful. 
Exposure Levels in Humans. Human exposure levels to acrylonitrile
can only be estimated based on average concentrations in air, food and
water. Direct studies of personal exposure levels for individuals with
exposures judged to be average and above average (e.g., people living
near industrial sources or hazardous waste sites) would be helpful in
improving total dose estimates, and in identifying exposure pathways of
concern. 
Exposure Registries. No exposure registries for acrylonitrile were
located. This compound is not currently one of the compounds for which
a subregistry has been established in the National Exposure Registry.
The compound will be considered in the future when chemical selection is
made for subregistries to be established. The information that is
amassed in the National Exposure Registry facilitates the
epidemiological research needed to assess adverse health outcomes that
may be related to the exposure to this compound. 
5.7.2 On-going Studies 
The Acrylonitrile Group, Inc. is currently performing an
acrylonitrile degradation study in groundwater and surrounding soil to
obtain kinetic data for hydrolysis, biodegradation, primary metabolites
and rates of mineralization. Radiolabeled material at three 
concentrations over three orders of magnitude will be used. The data





































































6. ANALYTICAL METHODS 
The purpose of this chapter is to describe the analytical methods
that are available for detecting and/or measuring and monitoring
acrylonitrile in environmental media and in biological samples. The
intent is not to provide an exhaustive list of analytical methods that
could be used to detect and quantify acrylonitrile. Rather, the
intention is to identify well-established methods that are used as the
standard methods of analysis. Many of the analytical methods used to
detect acrylonitrile in environmental samples are the methods approved
by federal agencies such as EPA and the National Institute for
Occupational Safety and Health (NIOSH). Other methods presented in this
chapter are those that are approved by a trade association such as the
Association of Official Analytical Chemists (AOAC) and the American
Public Health Association (APHA). Additionally, analytical methods are
included that refine previously used methods to obtain lower detection
limits, and/or to improve accuracy and precision. 
6.1 BIOLOGICAL MATERIALS 
Acrylonitrile in both biological and environmental samples is most
commonly determined by gas chromatography with a nitrogen-phosphorus
detector (GC/NPD) (Page 1985), gas chromatography/flame ionization
detection (GC/FID) (EPA 1982a), or gas chromatography/mass spectroscopy
(GC/MS) (Anderson and Harland 1980). Infrared spectroscopy (Jacobs and
Syrjala 1978) may also be used. In the handling of samples and
standards, acrylonitrile should be treated with precautions appropriate
for a probable human carcinogen. 
Comparatively little information is available in the literature on
the determination of acrylonitrile in biological materials. Methods
have been published for the determination of acrylonitrile in blood
(Anderson and Harland 1980; Freshour and Melcher 1983) and urine
(Houthuijs et al. 1982; Sakurai et al. 1978). Acrylonitrile was widely
used in the past as a fumigant, and it is possible that methods used for
the determination of other fumigants in biological materials (Walters
1986) could be adapted to the determination of acrylonitrile in such
samples. 
Methods for detection of acrylonitrile in biological materials are
summarized in Table 6-l. 
6.2 ENVIRONMENTAL SAMPLES 
The methods of choice for the determination of acrylonitrile in
environmental samples are GC/NPD (Page 1985), GC/FID (EPA 1982a), and
GC/MS (EPA 1982b). Multiple internal reflectance infrared spectrometry
(Jacobs and Syrjala 1978) is useful for monitoring low levels of

















6. ANALYTICAL METHODS 
The determination of acrylonitrile in air may be accomplished by
collection on a solid sorbet, such as activated charcoal, followed by
elution and gas chromatographic measurement (NIOSH 1984). 
EPA has published a method of analysis specific for acrylonitrile
in water (EPA 1982a) and a method applicable to its determination in
water along with other purgeable organics (EPA 1982b). Other standard
EPA methods are adaptable for the determination of acrylonitrile in
wastes (EPA 1986b). 
Methods for the determination of acrylonitrile in environmental
samples are summarized in Table 6-2. 
6.3 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of
the Public Health Service) to assess whether adequate information on the
health effects of acrylonitrile is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is
required to assure the initiation of a program of research designed to
determine the health effects (and techniques for developing methods to
determine such health effects) of acrylonitrile. 
The following categories of possible data needs have been
identified by a joint team of scientists from ATSDR, NTP, and EPA. They
are defined as substance-specific informational needs that, if met would
reduce or eliminate the uncertainties of human health assessment. In 
the future, the identified data needs will be evaluated and prioritized,
and a substance-specific research agenda will be proposed. 
6.3.1 Identification of Data Needs 
Method for Determining Biomarkers of Exposure and Effect. Exposure
to acrylonitrile can be determined by measuring parent acrylonitrile,
acrylonitrile metabolites and adducts. Good methods exist for detecting
and quantifying acrylonitrile in biological materials. These methods
are based on capillary gas chromatography, where a special problem is
introduction of analytes quantitatively and in a narrow band onto the
capillary GC. One of the most promising approaches to analyte transfer
is the use of cyrofocusing, in which analytes are condensed in a narrow
band on a trap or on the GC column itself. Improvements in cryofocusing
of volatile organic analytes for capillary GC determination (Washall and













6. ANALYTICAL METHODS 
Acrylonitrile metabolites have been measured in blood and urine,
but, except for measurement of thiocyanate, these methods have not been
developed for routine monitoring of exposed humans. Supercritical fluid
extraction/chromatography and immunoassay analysis are two areas of
intense current activity from which substantial advances in the
determination of acrylonitrile and its metabolites in biological samples
can be anticipated. The two techniques are complementary because
supercritical fluid extraction is especially promising for the removal
of analytes from sample material and immunoassay is very analyte- selective
and sensitive (Vanderlaan et al. 1988). 
Studies using radioactivity-labeled acrylonitrile indicate that
acrylonitrile or its metabolites form covalent adducts with cellular
macromolecules in most tissues. Studies to develop chemical or
immunological methods for measuring these adducts would be especially
valuable in detecting and perhaps even quantifying human exposure to
acrylonitrile. Adverse health effects demonstrated following exposure
to acrylonitrile, particularly acute exposures, were characteristic of
cyanide toxicity. Because these effects are also indicative of exposure
to many other toxicants, additional methods are needed for more specific
biomarkers of effects of acrylonitrile exposure. 
Methods for Determining Parent Compounds and Degradation Products
in Environmental Media. Methods for determining acrylonitrile in
environmental samples are quite good. It may be assumed that the normal
incentives for both research and the development of commercial methods
of analysis will result in new analytical methods for acrylonitrile that
have improved sensitivity and selectivity. Degradation products of
acrylonitrile in environmental media are difficult to determine. This
difficulty is not as much an analytical problem as it is a problem of
knowing the fundamental environmental chemistry of these compounds in
water, soil, air and biological systems. 
6.3.2 On-going Studies 
There exists an ongoing effort to develop a "Master Analytical
Scheme" for organic compounds in water (Michael et al. 1988). The
overall goal is the development of technology capable of detecting and
quantitatively measuring organic compounds at 0.1 µg/L in effluent
waters. Analytes are to include numerous semivolatile compounds and
some compounds that are only "semisoluble" in water, as well as volatile
compounds (boiling point, less than 15O°C). 
Studies designed to improve the determination of environmental
contaminants will continue to provide refinements and improvements in
the determination of acrylonitrile. The current high level of activity
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yield improved recoveries and sensitivities for the determination of
acrylonitrile in solid wastes, and the compound should be amenable to
supercritical fluid chromatographic analysis. Immunoassay analysis is
another area of intense current activity from which substantial advances
in the determination of acrylonitrile in environmental samples can be





7. REGULATIONS AND ADVISORIES 
Because of its potential to cause adverse health effects in exposed
people, a number of regulations and guidelines have been established for
acrylonitrile by various national and state agencies. These values are
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or
less, as specified in the Toxicological Profiles. 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical 
adsorbed per unit weight of organic carbon in the soil or sediment to
the concentration of the chemical in solution at equilibrium. 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment
or soil (i.e., the solid phase) divided by the amount of chemical in the
solution phase, which is in equilibrium with the solid phase, at a fixed
solid/solution ratio. It is generally expressed in micrograms of
chemical sorbed per gram of soil or sediment. 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
chemical in aquatic organisms at a specific time or during a discrete
time period of exposure divided by the concentration in the surrounding
water at the same time or during the same time period. 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study or
group of studies which produces significant increases in incidence of
cancer (or tumors) between the exposed population and its appropriate
control. 
Carcinogen -- A chemical capable of inducing cancer. 
Ceiling value (CL) -- A concentration of a substance that should not be 
exceeded, even instantaneously. 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as
specified in the Toxicological Profiles. 
Developmental Toxicity -- The occurrence of adverse effects on the 
developing organism that may result from exposure to a chemical prior to
conception (either parent), during prenatal development, or postnatally
to the time of sexual maturation. Adverse developmental effects may be
detected at any point in the life span of the organism. 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as
a result of prenatal exposure to a chemical; the distinguishing feature
between the two terms is the stage of development during which the
insult occurred. The terms, as used here, include malformations and
variations, altered growth, and in utero death. 
EPA Health Advisory -- An estimate of acceptable drinking water levels
for a chemical substance based on health effects information. A health 
advisory is not a legally enforceable federal standard, but serves as





















Immediately Dangerous to Life or Health (IDLH) -- The maximum 
environmental concentration of a contaminant from which one could escape
within 30 min without any escape-impairing symptoms or irreversible
health effects. 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364
days s as specified in the Toxicological Profiles. 
Immunologic Toxicity -- The occurrence of adverse effects on the immune 
system that may result from exposure to environmental agents such as
chemicals. 
In Vitro -- Isolated from the living organism and artificially
maintained, as in a test tube. 
In Vivo -- Occurring within the living organism. 
Lethal Concentration(LO) (LCLO) -- The lowest concentration of a them 
in air which has been reported to have caused death in humans or
animals. 
Lethal Concentration(50) (LC50) -- A calculated concentration of a 
chemical in air to which exposure for a specific length of time is
expected to cause death in 50% of a defined experimental animal
population. 
Lethal Dose(LO)(LDLO) -- The lowest dose of a chemical introduced by a
route other than inhalation that is expected to have caused death in
humans or animals. 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been 
calculated to cause death in 50% of a defined experimental animal
population. 
Lethal Time(5O) (LT50) -- A calculated period of time within which a
specific concentration of a chemical is expected to cause death in 50%
of a defined experimental animal population. 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of 
chemical in a study or group of studies which produces statistically or
biologically significant increases in frequency or severity of adverse
effects between the exposed population and its appropriate control. 
Malformations -- Permanent structural changes that may adversely affect

















Minimal Risk Level (MRL) -- An estimate of daily human exposure to a
chemical that is likely to be without an appreciable risk of deleterious
effects (noncancerous) over a specified duration of exposure. 
Mutagen -- A substance that causes mutations. A mutation is a change in
the genetic material in a body cell. Mutations can lead to birth
defects, miscarriages, or cancer. 
NeurotoxLcity -- The occurrence of adverse effects on the nervous system
following exposure to a chemical. 
No-Observed-Adverse-Effect Level (NOAEL) -- That dose of chemical at
which there are no statistically or biologically significant increases
in frequency or severity of adverse effects seen between the exposed
population and its appropriate control. Effects may be produced at this
dose, but they are not considered to be adverse. 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of
the concentrations of a chemical in n-octanol and water, in dilute
solution. 
Permissible Exposure Limit (PEL) -- An allowable exposure level in
workplace air averaged over an 8-hour shift. 
q1* -- The upper-bound estimate of the low-dose slope of the dose-
Response curve as determined by the multistage procedure. The q1* can 
be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually µg/L for
water, mg/kg/day for food, and µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps
an order of magnitude) of the daily exposure of the human population to
a potential hazard that is likely to be without risk of deleterious
effects during a lifetime. The RfD is operationally derived from the
NOAEL (from animal and human studies) by a consistent application of
uncertainty factors that reflect various types of data used to estimate
RfDs and an additional modifying factor, which is based on a
professional judgment of the entire database on the chemical. The RfDs
are not applicable to nonthreshold effects such as cancer. 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that
is considered reportable under CERCLA. Reportable quantities are: (1) 1
lb or greater or (2) for selected substances, an amount established by
regulation either under CERCLA or under Sect. 311 of the Clean Water






















Reproductive Toxicity -- The occurrence of adverse effects on the 
reproductive system that may result from exposure to a chemical. The
toxicity may be directed to the reproductive organs and/or the related
endocrine system. The manifestation of such toxicity may be noted as
alterations in sexual behavior, fertility, pregnancy outcomes, or
modifications in other functions that are dependent on the integrity of
this system. 
Short-Term Exposure Limit (STEL) -- The maximum concentration to which 
workers can be exposed for up to 15 min continually. No more than four
excursions are allowed per day, and there must be at least 60 min
between exposure periods. The daily TLV-TWA may not be exceeded. 
Target Organ Toxicity -- This term covers a broad range of adverse
effects on target organs or physiological systems (e.g., renal,
cardiovascular) extending from those arising through a single limited
exposure to those assumed over a lifetime of exposure to a chemical. 
Teratogen -- A chemical that causes structural defects that affect the 
development of an organism. 
Threshold Limit Value (TLV) -- A concentration of a substance to which 
most workers can be exposed without adverse effect. The TLV may be
expressed as a TWA, as a STEL, or as a CL. 
Time-weighted Average (TWA) -- An allowable exposure concentration
averaged over a normal 8-hour workday or 40-hour workweek. 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a
route other than inhalation, which is expected to cause a specific toxic
effect in 50% of a defined experimental animal population. 
Uncertainty Factor (UF) -- A factor used in operationally deriving the
RfD from experimental data. UFs are intended to account for (1) the
variation in sensitivity among the members of the human population, (2)
the uncertainty in extrapolating animal data to the case of humans, (3)
the uncertainty in extrapolating from data obtained in a study that is
of less than lifetime exposure, and (4) the uncertainty in using LOAEL


















A peer review panel was assembled for acrylonitrile. The panel
consisted of the following members: Dr. Ahmed Ahmed, Professor of
Environmental Pathology and Toxicology, Department of Pathology,
University of Texas Medical Branch, Galveston; Dr. Norman M. Trieff,
Professor of Environmental Toxicology, University of Texas Medical
Branch, Galveston; Dr. Sandor Szabo, Associate Professor of Pathology,
Department of Pathology, Brigham and Women's Hospital, Harvard Medical
School, Boston. These experts collectively have knowledge of
acrylonitrile's physical and chemical properties, toxicokinetics, key
health end points, mechanisms of action, human and animal exposure, and
quantification of risk to humans. All reviewers were selected in
conformity with the conditions for peer review specified in the
Superfund Amendments and Reauthorization Act of 1986, Section 110. 
A joint panel of scientists from ATSDR and EPA has reviewed the
peer reviewers' comments and determined which comments will be included
in the profile. A listing of the peer reviewers' comments not
incorporated in the profile, with a brief explanation of the rationale
for their exclusion, exists as part of the administrative record for
this compound. A list of databases reviewed and a list of unpublished
documents cited are also included in the administrative record. 
The citation of the peer review panel should not be understood to
imply their approval of the profile's final content. The responsibility
for the content of this profile lies with the Agency for Toxic
Substances and Disease Registry. 
